<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Vet Sci</journal-id><journal-id journal-id-type="iso-abbrev">Vet Sci</journal-id><journal-id journal-id-type="publisher-id">vetsci</journal-id><journal-title-group><journal-title>Veterinary Sciences</journal-title></journal-title-group><issn pub-type="epub">2306-7381</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39728983</article-id><article-id pub-id-type="pmc">PMC11680147</article-id>
<article-id pub-id-type="doi">10.3390/vetsci11120643</article-id><article-id pub-id-type="publisher-id">vetsci-11-00643</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Porcine Epidemic Diarrhea Virus Infection of Porcine Intestinal Epithelial Cells Causes Mitochondrial DNA Release and the Activation of the NLRP3 Inflammasome to Mediate Interleukin-1&#x003b2; Secretion</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bao</surname><given-names>Di</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-vetsci-11-00643" ref-type="aff">1</xref><xref rid="fn1-vetsci-11-00643" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5678-6001</contrib-id><name><surname>Yi</surname><given-names>Shushuai</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><xref rid="af2-vetsci-11-00643" ref-type="aff">2</xref><xref rid="fn1-vetsci-11-00643" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Luobing</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><xref rid="af3-vetsci-11-00643" ref-type="aff">3</xref><xref rid="fn1-vetsci-11-00643" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Han</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="af1-vetsci-11-00643" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Jiuyuan</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><xref rid="af1-vetsci-11-00643" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Wei</surname><given-names>Yiming</given-names></name><xref rid="af1-vetsci-11-00643" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Hu</surname><given-names>Guixue</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-vetsci-11-00643" ref-type="aff">1</xref><xref rid="c1-vetsci-11-00643" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Xinxin</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af3-vetsci-11-00643" ref-type="aff">3</xref><xref rid="c1-vetsci-11-00643" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Carrasco Otero</surname><given-names>Librado</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-vetsci-11-00643"><label>1</label>College of Veterinary Medicine, Jilin Agricultural University, Changchun 130118, China; <email>baodi666666@gmail.com</email> (D.B.); <email>zhaohan4566@163.com</email> (H.Z.); <email>liujiuyuan9916@163.com</email> (J.L.); <email>18525182253@163.com</email> (Y.W.)</aff><aff id="af2-vetsci-11-00643"><label>2</label>College of Veterinary Medicune, Jilin Agricultural Science and Technology University, Jilin 132109, China; <email>yss930117@163.com</email></aff><aff id="af3-vetsci-11-00643"><label>3</label>Institute of Animal Husbandry and Veterinary Medicine, Jilin Academy of Agricultural Sciences, Kemao Street No. 186, Gongzhuling 136100, China; <email>a13630969537@163.com</email></aff><author-notes><corresp id="c1-vetsci-11-00643"><label>*</label>Correspondence: <email>huguixue901103@163.com</email> (G.H.); <email>18686637873@163.com</email> (X.L.)</corresp><fn id="fn1-vetsci-11-00643"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>12</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2024</year></pub-date><volume>11</volume><issue>12</issue><elocation-id>643</elocation-id><history><date date-type="received"><day>31</day><month>10</month><year>2024</year></date><date date-type="rev-recd"><day>04</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>06</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2024 by the authors.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract abstract-type="plain-language-summary"><title>Simple Summary</title><p>Porcine epidemic diarrhea virus (PEDV) poses a significant threat to piglets and severely undermines the healthy development of the pig breeding industry. This is primarily due to the fact that infection in piglets can lead to severe inflammatory diarrhea. The activation of inflammasomes within cells is closely linked to pathogen invasion and the stress imposed by the internal environment. This article aims to investigate the inflammatory response elicited by PEDV in cells and the potential mechanisms underlying the activation of inflammasomes. We conducted in vitro experiments to assess mitochondrial damage in cells following viral infection, measure the expression levels of the NLRP3 inflammasome and IL-1&#x003b2;, and evaluate the activation pathway of the NLRP3 inflammasome in PEDV-infected porcine small intestinal epithelial cells. Our findings indicate that PEDV induces mitochondrial dysfunction, facilitates the release of mitochondrial DNA, and activates the NLRP3 inflammasome. Concurrently, reactive oxygen species generated by mitochondria activate the NF-&#x003ba;B signaling pathway. Notably, inhibiting the release of mitochondrial reactive oxygen species and mitochondrial DNA reduces the IL-1&#x003b2; release associated with viral infection. This study underscores the potential of mitochondrial DNA as a target for the control of inflammation in cases of porcine epidemic diarrhea.</p></abstract><abstract><title>Abstract</title><p>Porcine epidemic diarrhea virus (PEDV) induces enteritis and diarrhea in piglets. Mitochondrial DNA (mtDNA) contributes to virus-induced inflammatory responses; however, the involvement of inflammasomes in PEDV infection responses remains unclear. We investigated the mechanism underlying inflammasome-mediated interleukin (IL)-1&#x003b2; secretion during the PEDV infection of porcine intestinal epithelial (IPEC-J2) cells. IL-1&#x003b2; production and caspase-1 activity were assessed by quantitative PCR and enzyme-linked immunosorbent assay. NLRP3 inflammasome activation was assessed using immunoprecipitation experiments. Mitochondrial damage was evaluated by analyzing the mitochondrial membrane potential and ATP levels and by the flow cytometry examination of mitochondrial reactive oxygen species (mtROS). Mitochondria and mtDNA localization were observed using immunofluorescence. The inhibition of mtROS and mtDNA production allowed NLRP3 inflammasome and IL-1&#x003b2; expression detection and the evaluation of the pathway underlying NLRP3 inflammasome activation in PEDV-infected IPEC-J2 cells. IPEC-J2 cells upregulated IL-1&#x003b2; upon PEDV infection, where mature IL-1&#x003b2; secretion depended on caspase-1 activity, triggered NLRP3 inflammasome expression and assembly, and caused mitochondrial dysfunction, leading to mtDNA release and NLRP3 inflammasome activation, while mtROS contributed to NF-&#x003ba;B pathway activation, enhancing IL-1&#x003b2; secretion. This is the first demonstration of the mechanism underlying mtDNA release and NLRP3 inflammasome activation facilitating IL-1&#x003b2; secretion from PEDV-infected IPEC-J2 cells. These data enhance our understanding of the inflammatory mechanisms triggered by PEDV.</p></abstract><kwd-group><kwd>PEDV</kwd><kwd>mtDNA</kwd><kwd>NLRP3</kwd><kwd>IPEC-J2</kwd><kwd>IL-1&#x003b2;</kwd><kwd>inflammation</kwd></kwd-group><funding-group><award-group><funding-source>Natural Science Foundation of Jilin Province</funding-source><award-id>20230101257JC</award-id></award-group><award-group><funding-source>National Natural Science Foundation of China</funding-source><award-id>32072857</award-id></award-group><funding-statement>This work was supported by grants from the National Natural Science Foundation of China (32072857) and the Natural Science Foundation of Jilin Province, China (20230101257JC).</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-vetsci-11-00643"><title>1. Introduction</title><p>Porcine epidemic diarrhea is an acute, highly contagious, intestinal infectious disease caused by porcine epidemic diarrhea virus (PEDV). PEDV infection can lead to acute viremia, severe atrophic enteritis (mainly in the jejunum and ileum), and increased inflammation and innate immune responses, with significantly elevated expression levels of pro-inflammatory cytokines, such as interleukin (IL)-1&#x003b2;, TNF-&#x003b1;, IL-6, and IL-8, having important roles in the PEDV infection process [<xref rid="B1-vetsci-11-00643" ref-type="bibr">1</xref>,<xref rid="B2-vetsci-11-00643" ref-type="bibr">2</xref>,<xref rid="B3-vetsci-11-00643" ref-type="bibr">3</xref>]. Inflammasomes are pattern recognition receptors in the cytoplasm with integral functions in innate immune responses [<xref rid="B4-vetsci-11-00643" ref-type="bibr">4</xref>]; they mainly comprise an inflammasome receptor (NLR or ALR), the adapter protein, ASC, and pro-caspase-1 [<xref rid="B5-vetsci-11-00643" ref-type="bibr">5</xref>]. When the inflammasome receptor is activated, ASC and pro-caspase-1 are recruited to form an inflammasome complex via the PYD and CARD domains [<xref rid="B6-vetsci-11-00643" ref-type="bibr">6</xref>]. The activated inflammasome induces the generation of caspase-1 protein with an effector function from pro-caspase-1, and active caspase-1 cleaves the IL-1&#x003b2; precursor, pro-IL-1&#x003b2;, to induce its maturation [<xref rid="B7-vetsci-11-00643" ref-type="bibr">7</xref>,<xref rid="B8-vetsci-11-00643" ref-type="bibr">8</xref>]. IL-1&#x003b2; secretion is regulated by two signaling pathways. The first is NF-&#x003ba;B signaling; after the activation of the NF-&#x003ba;B pathway, pro-IL-1&#x003b2; protein can be produced through nuclear transcription and translation [<xref rid="B9-vetsci-11-00643" ref-type="bibr">9</xref>,<xref rid="B10-vetsci-11-00643" ref-type="bibr">10</xref>,<xref rid="B11-vetsci-11-00643" ref-type="bibr">11</xref>]. In the second signaling pathway regulating IL-1&#x003b2; secretion, pathogen-associated molecular patterns or damage-associated molecular patterns (DAMPs) activate the inflammasome by inducing specific physiological changes in cells, leading to pro-IL-1&#x003b2; cleavage by caspase-1 and the secretion of mature IL-1&#x003b2; to exert its biological functions [<xref rid="B12-vetsci-11-00643" ref-type="bibr">12</xref>]. Various viruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), human immunodeficiency virus (HIV), hantavirus, African swine fever virus, pseudorabies virus, porcine reproductive and respiratory syndrome virus (PRRSV), and Newcastle disease virus, can induce the maturation and secretion of IL-1&#x003b2;/IL-18, leading to pyroptosis through the activation of the inflammasome assembly, and thereby enhance the inflammatory response [<xref rid="B13-vetsci-11-00643" ref-type="bibr">13</xref>]. The infection of porcine intestinal epithelial cells (IPEC-J2) by porcine epidemic diarrhea virus (PEDV) can activate NF-&#x003ba;B signaling through Toll-like receptors (TLRs) 2, 3, and 9. Notably, TLR2 plays a significant role in the activation of NF-&#x003ba;B through the PEDV structural N protein [<xref rid="B14-vetsci-11-00643" ref-type="bibr">14</xref>]. Simultaneously, the non-structural PEDV protein, nsp4, also activates NF-&#x003ba;B signaling to upregulate IL-1&#x003b1;, IL-1&#x003b2;, and TNF-&#x003b1; and inhibit PEDV replication [<xref rid="B1-vetsci-11-00643" ref-type="bibr">1</xref>]. Transcriptome analysis showed that IL-1&#x003b2; was significantly upregulated in the PEDV-infected small intestinal mucosa [<xref rid="B15-vetsci-11-00643" ref-type="bibr">15</xref>]; however, the detailed molecular mechanism by which the inflammasome mediates IL-1&#x003b2; production after PEDV infection has yet to be clarified.</p><p>Mitochondria are the main source of ATP and are important in fighting viral infections [<xref rid="B16-vetsci-11-00643" ref-type="bibr">16</xref>,<xref rid="B17-vetsci-11-00643" ref-type="bibr">17</xref>]. Mitochondria can release substances, such as reactive oxygen species (ROS) and mitochondrial DNA (mtDNA), in response to cellular stress and the loss of homeostasis [<xref rid="B18-vetsci-11-00643" ref-type="bibr">18</xref>]. These substances are commonly known as DAMPs, and their release triggers an immune response. Dengue virus (DENV) and PRRSV can both induce mtDNA release and induce ROS production, as well as mediating inflammasome activation [<xref rid="B19-vetsci-11-00643" ref-type="bibr">19</xref>,<xref rid="B20-vetsci-11-00643" ref-type="bibr">20</xref>]. Further, the influenza A virus M2 protein can trigger mtDNA release in the cytoplasm and stimulate cGAS- and DDX41-dependent innate immune responses [<xref rid="B21-vetsci-11-00643" ref-type="bibr">21</xref>]. To date, most investigations of PEDV-mediated mitochondrial antiviral signals have focused on apoptosis and found that PEDV 3CLpro can cause the collapse of the mitochondrial membrane potential [<xref rid="B22-vetsci-11-00643" ref-type="bibr">22</xref>]; however, the inflammatory mechanism mediated by PEDV remains unclear. </p><p>In this study, we first demonstrated that IL-1&#x003b2; was secreted following the PEDV infection of IPEC-J2 cells and then investigated whether IL-1&#x003b2; secretion during the infection process was mediated by the NLRP3 inflammasome. In addition, we explored whether mtDNA release after PEDV infection mediated mitochondrial dysfunction and whether this was related to NLRP3 inflammasome activation. Our study is the first to assess the inflammatory mechanism by which PEDV activates the NLRP3 inflammasome through mtDNA release to mediate IL-1&#x003b2; secretion. Our findings provide a useful reference for the study of the inflammatory mechanisms involved during PEDV infection and provide new insights to inform the development of targeted drugs.</p></sec><sec id="sec2-vetsci-11-00643"><title>2. Materials and Methods</title><sec id="sec2dot1-vetsci-11-00643"><title>2.1. Cell Lines and Virus Strains</title><p>The porcine intestinal epithelial cell line IPEC-J2 and PEDV strain CV777 were maintained by the School of Veterinary Medicine, Jilin Agricultural University. IPEC-J2 cells were recovered and cultured in DMEM F12 (SH30271.FS, HyClone, Logan, UT, USA) containing 10% fetal calf serum (04-001-1ACS, BI, Kibbutz Beit Hamek, Israel). Cells were digested with 0.25% trypsin (SH30042.01, HyClone, Logan, UT, USA) for passage.</p><p>After the IPEC-J2 cells reached 80% confluence, the culture medium was discarded under sterile conditions, the cells were rinsed three times with sterile PBS, and the virus solution was then added. Then, the cells were placed in a 37 &#x000b0;C constant-temperature incubator for 1&#x02013;2 h to allow the virus to bind to the cell membrane. Next, the inoculum was discarded, the cells were washed three times with PBS, and serum-free DMEM F12 was added, before incubation in a 37 &#x000b0;C constant-temperature incubator to wait for cell lesions to develop.</p></sec><sec id="sec2dot2-vetsci-11-00643"><title>2.2. Quantitative PCR</title><p>Total cellular RNA was extracted using a total cell RNA extraction kit (BSC60S1, Bioer, Hangzhou, China) and then reverse-transcribed for fluorescence quantitative PCR experiments. The primers used to amplify the porcine <italic toggle="yes">IL-1&#x003b2;</italic> (M86725.1), <italic toggle="yes">NLRP3</italic> (JQ219660.1), and <italic toggle="yes">ASC</italic> (AB873106.1) sequences published in the GenBank database by real-time PCR were designed using the Primer Premier 5.0 software. The <italic toggle="yes">GAPDH</italic> gene was used as an internal control. The primers were synthesized by Shanghai Sangon Bioengineering Co., Ltd. (Shanghai, China), and their sequences are listed in <xref rid="vetsci-11-00643-t001" ref-type="table">Table 1</xref>.</p></sec><sec id="sec2dot3-vetsci-11-00643"><title>2.3. siRNA</title><p>Lipofectamine 3000 transfection reagent (L3000001, Invitrogen, Waltham, MA, USA) was used according to the manufacturer&#x02019;s instructions. The reagent was mixed with p3000 and siRNA and incubated for 15 min before being added to a six-well plate. The NLRP3 siRNAs used for transfection were synthesized by Saisuofei Biotechnology Co., Ltd. (Wuxi, China), and their sequences are provided in <xref rid="vetsci-11-00643-t002" ref-type="table">Table 2</xref>.</p></sec><sec id="sec2dot4-vetsci-11-00643"><title>2.4. Enzyme-Linked Immunosorbent Assay (ELISA)</title><p>The porcine IL-1&#x003b2; levels were assessed using an ELISA kit (MB-2562A, Enzyme Biotechnology, Shanghai, China). Briefly, 100 &#x003bc;L cell supernatant samples were added to ELISA reaction plates and incubated at room temperature for 2 h; then, the samples were aspirated and the plates washed five times. Next, a detection antibody was added and the samples incubated at room temperature for 1 h before the antibody was discarded and the plates were washed five times. Then, 100 &#x000b5;L enzyme working reagent was added to each well, the plates were incubated at room temperature for 30 min, the solution was discarded, and the samples were washed seven times. A one-step substrate reagent was added to each well and they were incubated for 30 min at room temperature. Then, 50 &#x000b5;L stop solution was added to each well, and the absorbance at 450 nm was read within 15 min. Finally, a standard curve was drawn to calculate the IL-1&#x003b2; protein content in the cell supernatant samples.</p></sec><sec id="sec2dot5-vetsci-11-00643"><title>2.5. Caspase-1 Activity Detection</title><p>The cell culture medium was discarded and the cells washed three times with PBS, followed by the addition of 100 &#x000b5;L of cell lysis solution. A caspase-1 activity detection kit (C1102, Beyotime, Shanghai, China) was used to set up reactions, which were incubated at 37 &#x000b0;C for 1&#x02013;2 h. Then, the absorbance was measured on a microplate reader at 405 nm, a standard curve drawn, and the caspase-1 enzyme activity calculated.</p></sec><sec id="sec2dot6-vetsci-11-00643"><title>2.6. Western Blot Analysis</title><p>The PEDV nucleocapsid, N, IL-1&#x003b2;, NLRP3, ASC, caspase-1, p65, and pp65 protein levels were analyzed by Western blotting. Specifically, the cell supernatants were discarded and the cells were washed twice with PBS and then lysed in lysis buffer (PC101, Yazyme, Shanghai, China) containing protease inhibitors. The protein concentration was determined using a BCA kit (A55860, Thermo, Waltham, MA, USA) and the protein concentrations balanced by dilution with lysis buffer. After the separation of the protein samples by 10&#x02013;12% SDS polyacrylamide gel electrophoresis, the samples were transferred to a polyvinylidene fluoride membrane (IPVH00010, Millipore, Darmstadt, Germany), which was then blocked with a quick blocking solution (PS108P, Yazyme, Shanghai, China) for 15 min and incubated with the primary antibody overnight. The membranes were washed five times and then incubated with HRP-labeled anti-rabbit secondary antibody (S0001, Affinity, Jiangshu, China) for 60 min. After washing the membrane a further five times, the Western blots were observed using a chemiluminescence imaging system (GS-800; Bio-Rad, Shanghai, China).</p><p>The primary antibodies used in this study included mouse monoclonal PEDV N (BGT-ANT-37707, Biogradetech, Waltham, MA, USA), rabbit polyclonal anti-IL-1&#x003b2; (bs-0812R, Bioss, Beijing, China), rabbit monoclonal ASC (WL02462, Wanleibio, Shenyang, China), rabbit monoclonal NLRP3 (WL02635, Wanleibio, Shenyang, China), rabbit monoclonal IL-1&#x003b2; P17 (WL00891, Wanleibio, Shenyang, China), rabbit polyclonal antibody caspase-1 (22915-1-AP, Proteintech, Chicago, IL, USA), rabbit monoclonal NF-&#x003ba;B p65 (AF5006, Affinity, Jiangshu, China), NF-&#x003ba;B pp65 (AF2006, Affinity, Jiangshu, China), and rabbit monoclonal GAPDH (GB15004-100, Servicebio, Wuhan, China).</p></sec><sec id="sec2dot7-vetsci-11-00643"><title>2.7. Immunoprecipitation Assay</title><p>IPEC-J2 cells were stimulated with 100 ng/mL lipopolysaccharides (LPS; L2630, Sigma, St. Louis, MA, USA) for 9 h; then, ATP (HY-B2176, MCE, Monmouth, NJ, USA) was added at a final concentration of 5 mmol for 4 h to generate the LPS+ATP stimulation group. Simultaneously, cells to be tested were collected for lysis according to the method described above (<xref rid="sec2dot6-vetsci-11-00643" ref-type="sec">Section 2.6</xref>). NLRP3 or ASC antibodies (5 &#x000b5;g) were mixed with the cleaved protein, and the primary antibody homologous serum was used as a control. Then, the samples were incubated overnight at 4 &#x000b0;C to form antigen&#x02013;antibody complexes. The magnetic beads in the classic Protein A/G immunoprecipitation kit (YJ201, Yazyme, Shanghai, China) were washed, added to the antigen&#x02013;antibody complex, mixed well, and incubated at 4 &#x000b0;C overnight. The beads were then collected using a magnetic stand, the supernatant discarded, and the beads washed three times with PBS. Finally, the proteins bound to the beads were eluted for Western blot analysis.</p></sec><sec id="sec2dot8-vetsci-11-00643"><title>2.8. Inhibitor Treatment of IPEC-J2 Cells</title><p>The tool at <uri xlink:href="https://www.medchemexpress.cn/dilution-calculator.htm">https://www.medchemexpress.cn/dilution-calculator.htm</uri> (accessed on 10 October 2024) was used to calculate the specific concentration of each inhibitor, which was then added to the cell culture medium and processed for 1 h, followed by the replacement of the culture medium. The inhibitors used included Mito-TEMPO (HY-112879, MCE, Monmouth, NJ, USA), to inhibit mitochondrial ROS production; Ac-YVAD-cmk (HY-16990, MCE, Monmouth, NJ, USA), to inhibit caspase-1 activity; BAY11-7082 (HY-13453 MCE, Monmouth, NJ, USA), to inhibit NF-&#x003ba;B pathway activation; and MCC950 (HY-12815, MCE, Monmouth, NJ, USA), to inhibit NLRP3 inflammasome activation.</p></sec><sec id="sec2dot9-vetsci-11-00643"><title>2.9. Detection of Mitochondrial Membrane Potential, ATP, and Mitochondrial Reactive Oxygen Species (mtROS)</title><p>The mitochondrial membrane potential was detected by staining cells with JC-1 dye (C2006, Beyotime, Shanghai, China) for 30 min and observing the fluorescence intensity of JC-1 monomers (green fluorescence) and JC-1 aggregates (red fluorescence) using a fluorescence microscope (BX53, Olympus, Tokyo, Japan). After the IPEC-J2 cells were treated with the lysis buffer from the enhanced ATP detection kit (S0027, Beyotime, Shanghai, China), they were centrifuged at 12,000&#x000d7; <italic toggle="yes">g</italic> for 5 min and the supernatants collected to analyze the total ATP levels. To detect the mtROS levels, a MitoSOX Red mitochondrial superoxide probe (40778ES50, Yeasen, Shanghai, China) was used to detect the fluorescence intensity of the ROS produced by the mitochondria in the cells. The probe was diluted to a concentration of 1 &#x000b5;M with PBS. After the cells were washed, the probe was added and the samples incubated in a 37 &#x000b0;C water bath for 30 min in the dark, followed by the analysis of the fluorescence levels using a flow cytometer.</p></sec><sec id="sec2dot10-vetsci-11-00643"><title>2.10. mtDNA Localization</title><p>The IPEC-J2 cells were washed three times with HBSS, Mito-Tracker Red CMXRos (C1049B, Beyotime, Shanghai, China) was used to label mitochondria, and an appropriate amount of probe was added, according to the reagent instructions, and it was incubated with the cells for 30 min. After washing the cells three times with HBSS, an appropriate amount of culture medium was added and the cells incubated with Picogreen (12641ES01, Yeasen, Shanghai, China) for 1.5 h, followed by the observation of colocalization under a fluorescence microscope.</p></sec><sec id="sec2dot11-vetsci-11-00643"><title>2.11. DNase I Protein Transfection</title><p>Cells were grown to 80% confluence in 24-well culture plates before protein transfection. To prepare the protein transfection complex, 5 &#x003bc;g DNase I (HY-108882, MCE, Monmouth, NJ, USA) and Starvio (T81001, EMI Biotechnology, Changzhou, China) were mixed, according to the instructions. After standing for 3 min, the Trans buffer was added to 50 &#x003bc;L and incubated for 15 min. During this period, the cells were washed twice with 37 &#x000b0;C preheated PBS and then 500 &#x003bc;L serum-free DMEM F2 added. Next, 50 &#x003bc;L of the protein transfection complex was added to the serum-free DMEM F2, and the samples were placed in a 37 &#x000b0;C constant-temperature cell incubator and incubated for 4 h to complete protein transfection.</p></sec><sec id="sec2dot12-vetsci-11-00643"><title>2.12. Statistical Analyses</title><p>Data are expressed as the mean and standard deviation. The <italic toggle="yes">t</italic> test was used to compare the mean values between two groups, and a one-way analysis of variance with the Bonferroni correction was applied to compare the mean values among multiple groups. Data were analyzed using the GraphPad Prism v8.0 software. Significance was defined as <italic toggle="yes">p</italic> &#x0003c; 0.05.</p></sec></sec><sec sec-type="results" id="sec3-vetsci-11-00643"><title>3. Results</title><sec id="sec3dot1-vetsci-11-00643"><title>3.1. PEDV Infects IPEC-J2 Cells to Induce IL-1&#x003b2; Production</title><p>IL-1&#x003b2; is an inflammation-related cytokine that also has key roles in cell proliferation, differentiation, and apoptosis [<xref rid="B23-vetsci-11-00643" ref-type="bibr">23</xref>,<xref rid="B24-vetsci-11-00643" ref-type="bibr">24</xref>]. PEDV infection increases the expression of pro-inflammatory cytokines and chemokines in in vitro experiments, and pro-inflammatory cytokines, such as IL-1&#x003b2;, inhibit PEDV replication in vitro [<xref rid="B14-vetsci-11-00643" ref-type="bibr">14</xref>,<xref rid="B25-vetsci-11-00643" ref-type="bibr">25</xref>]. Therefore, we first assessed the IL-1&#x003b2; expression levels in IPEC-J2 cells after PEDV infection. The Western blot analysis was conducted on IPEC-J2 cells infected with PEDV for 24 h. The results demonstrated that the N protein of PEDV increased in a dose-dependent manner. Furthermore, the level of the N protein in IPEC-J2 cells rose with the extension of the infection duration. These findings suggest that PEDV replicates efficiently in IPEC-J2 cells (<xref rid="vetsci-11-00643-f001" ref-type="fig">Figure 1</xref>a). The real-time quantitative PCR analysis demonstrated that the <italic toggle="yes">IL-1&#x003b2;</italic> mRNA expression levels showed an upward trend 8 h after the infection of the IPEC-J2 cells with PEDV and reached a peak at 24 h (<xref rid="vetsci-11-00643-f001" ref-type="fig">Figure 1</xref>b). Further, the ELISA of the cell supernatants revealed that the IL-1&#x003b2; secretion from PEDV-infected IPEC-J2 cells also showed a comparable upward trend (<xref rid="vetsci-11-00643-f001" ref-type="fig">Figure 1</xref>c). In addition, infection with different doses of PEDV led to a dose-dependent increasing trend in <italic toggle="yes">IL-1&#x003b2;</italic> mRNA expression (<xref rid="vetsci-11-00643-f001" ref-type="fig">Figure 1</xref>d), while the IL-1&#x003b2; secretion in the cell supernatants also increased in a dose-dependent manner, according to the ELISA results (<xref rid="vetsci-11-00643-f001" ref-type="fig">Figure 1</xref>e). The Western blot analysis demonstrated an increasing trend in the IL-1&#x003b2; protein levels with an increasing PEDV exposure time and dose. During this period, the mature IL-1&#x003b2; P17 protein also showed the same increasing trend (<xref rid="vetsci-11-00643-f001" ref-type="fig">Figure 1</xref>f,g). Taken together, these results indicate that the PEDV infection of IPEC-J2 cells promotes IL-1&#x003b2; expression and secretion.</p></sec><sec id="sec3dot2-vetsci-11-00643"><title>3.2. PEDV Infection of IPEC-J2 Cells Induces Increased Caspase-1 Enzyme Activity</title><p>Enzymatically active caspase-1 protein is necessary for the secretion of biologically active IL-1&#x003b2; [<xref rid="B26-vetsci-11-00643" ref-type="bibr">26</xref>]. Therefore, we analyzed the enzymatic activity of caspase-1 after the PEDV infection of IPEC-J2 cells and found that the caspase-1 enzyme activity increased (<xref rid="vetsci-11-00643-f002" ref-type="fig">Figure 2</xref>a). Further, the Western blot assays demonstrated that the P20 protein expression increased with the infection time after cleavage by caspase-1 (<xref rid="vetsci-11-00643-f002" ref-type="fig">Figure 2</xref>b). Following the infection of IPEC-J2 cells with different doses of PEDV, the caspase-1 enzyme activity increased in a dose-dependent manner (<xref rid="vetsci-11-00643-f002" ref-type="fig">Figure 2</xref>c,d). In addition, the treatment of IPEC-J2 cells with the caspase-1 inhibitor, Ac-YVAD-cmk, reduced IL-1&#x003b2; secretion (<xref rid="vetsci-11-00643-f002" ref-type="fig">Figure 2</xref>e). Together, these data indicate that the PEDV infection of IPEC-J2 cells promotes caspase-1 enzymatic activity and that IL-1&#x003b2; secretion depends on this caspase-1 activity.</p></sec><sec id="sec3dot3-vetsci-11-00643"><title>3.3. PEDV-Infected IPEC-J2 Cells Activate the NLRP3 Inflammasome</title><p>Our findings demonstrate that the PEDV infection of IPEC-J2 cells promotes the secretion of mature IL-1&#x003b2;. Previous studies have shown that RNA viruses can induce mature IL-1&#x003b2; secretion by activating the NLRP3 inflammasome pathway at different stages of infection [<xref rid="B27-vetsci-11-00643" ref-type="bibr">27</xref>,<xref rid="B28-vetsci-11-00643" ref-type="bibr">28</xref>,<xref rid="B29-vetsci-11-00643" ref-type="bibr">29</xref>]. To determine whether the NLRP3 inflammasome is activated after PEDV infection, we detected its expression and found that the <italic toggle="yes">NLRP3</italic> inflammasome mRNA expression increased in a time- and dose-dependent manner following the infection of IPEC-J2 cells with PEDV (<xref rid="vetsci-11-00643-f003" ref-type="fig">Figure 3</xref>a,b), demonstrating that the PEDV infection of IPEC-J2 cells promoted <italic toggle="yes">NLRP3</italic> mRNA expression. Further, the <italic toggle="yes">ASC</italic> mRNA expression was also upregulated after the PEDV infection of IPEC-J2 cells (<xref rid="vetsci-11-00643-f003" ref-type="fig">Figure 3</xref>c,d). Next, a co-immunoprecipitation experiment using A/G magnetic beads was conducted, with the NLRP3 and ASC antibodies as bait and primary antibody homologous serum as a negative control. The results showed that IPEC-J2 cells infected with PEDV and cells in the LPS+ATP induction group contained NLRP3 assembled in inflammasomes with ASC and pro-caspase-1 (<xref rid="vetsci-11-00643-f003" ref-type="fig">Figure 3</xref>e,f). In summary, the NLRP3 inflammasome was activated in PEDV-infected IPEC-J2 cells.</p></sec><sec id="sec3dot4-vetsci-11-00643"><title>3.4. PEDV-Infected IPEC-J2 Cells Induce IL-1&#x003b2; Production by Activating the NLRP3 Inflammasome</title><p>Next, we determined whether IL-1&#x003b2; production induced by the PEDV infection of IPEC-J2 cells was related to NLRP3 inflammasome activation. Cells were treated with the NLRP3 inhibitor MCC950 and the amount of IL-1&#x003b2; secreted in the cell supernatants was detected after PEDV infection. The results showed that, after NLRP3 inflammasome inhibition, IL-1&#x003b2; secretion in the cell supernatants was significantly decreased (<xref rid="vetsci-11-00643-f004" ref-type="fig">Figure 4</xref>a). In addition, siRNA transfection was used to silence the <italic toggle="yes">NLRP3</italic> inflammasome mRNA, which also resulted in significantly reduced IL-1&#x003b2; secretion in the cell supernatant (<xref rid="vetsci-11-00643-f004" ref-type="fig">Figure 4</xref>b); however, neither MCC950 nor siNLRP3 significantly influenced <italic toggle="yes">IL-1&#x003b2;</italic> mRNA transcription in IPEC-J2 cells (<xref rid="vetsci-11-00643-f004" ref-type="fig">Figure 4</xref>c,d). Nevertheless, the Western blot analysis of the inflammasome protein components showed that treatment with MCC950 and SiNLRP3 inhibited the expression of ASC, caspase-1, and the IL-1&#x003b2; p17 protein in the cells (<xref rid="vetsci-11-00643-f004" ref-type="fig">Figure 4</xref>e,f). Together, these results indicate that PEDV-infected IPEC-J2 cells induce IL-1&#x003b2; secretion by activating the NLRP3 inflammasome.</p></sec><sec id="sec3dot5-vetsci-11-00643"><title>3.5. PEDV Infection of IPEC-J2 Cells Causes Mitochondrial Dysfunction, Leading to mtROS Production and mtDNA Release</title><p>Mitochondria participate in a wide range of innate immune pathways, and there is increasing evidence supporting a role for mitochondria in promoting innate immune activation after cell injury and stress through ROS production [<xref rid="B16-vetsci-11-00643" ref-type="bibr">16</xref>,<xref rid="B30-vetsci-11-00643" ref-type="bibr">30</xref>], where mtROS can accelerate the activation of the NLRP3 inflammasome [<xref rid="B31-vetsci-11-00643" ref-type="bibr">31</xref>]. In addition, various physiological or pathological stressors can also trigger mtDNA release into the cytoplasm, thereby activating the NLRP3 inflammasome [<xref rid="B32-vetsci-11-00643" ref-type="bibr">32</xref>,<xref rid="B33-vetsci-11-00643" ref-type="bibr">33</xref>]. To clarify the role of mitochondria in mediating inflammasome activity in PEDV-infected IPEC-J2 cells, we studied the mitochondrial function of IPCJ2 cells during PEDV infection. The mitochondrial membrane potential was detected by JC-1 fluorescent molecule staining after PEDV infection. We observed that PEDV infection reduced the mitochondrial membrane potential (<xref rid="vetsci-11-00643-f005" ref-type="fig">Figure 5</xref>a). In addition, PEDV infection significantly reduced the ATP production by IPEC-J2 cells (<xref rid="vetsci-11-00643-f005" ref-type="fig">Figure 5</xref>b). These findings show that PEDV infection causes mitochondrial dysfunction. Next, we used MitoROS probes to selectively target mitochondria in living cells; MitoROS probes are rapidly oxidized by superoxide and cannot be oxidized by other ROS or reactive nitrogen species. Oxidation products emit strong fluorescence in cells; therefore, we stained the ROS produced by the mitochondria after PEDV infection and analyzed them through flow cytometry. The results showed that PEDV infection caused mtROS accumulation in the cells (<xref rid="vetsci-11-00643-f005" ref-type="fig">Figure 5</xref>c). In addition, we stained IPEC-J2 cells infected with PEDV with Mitotracker (red, mitochondrial indicator) and Picogreen (green, mitochondrial DNA and nuclear DNA indicator). Subsequent immunofluorescence microscopy observation demonstrated that mtDNA and mitochondria were increased in non-overlapping staining areas after PEDV infection, indicating that part of the mtDNA was released outside of the mitochondria (<xref rid="vetsci-11-00643-f005" ref-type="fig">Figure 5</xref>d). These data indicate that the PEDV infection of IPEC-J2 cells can lead to mitochondrial dysfunction, the accumulation of mtROS, and the release of mtDNA.</p></sec><sec id="sec3dot6-vetsci-11-00643"><title>3.6. mtROS Activates NF-&#x003ba;B Signaling After PEDV Infection of IPEC-J2 Cells</title><p>NF-&#x003ba;B is a nuclear transcription factor with an important role in the regulation of inflammatory responses. PEDV can activate NF-&#x003ba;B through the TLR2, TLR3, and TLR9 pathways [<xref rid="B14-vetsci-11-00643" ref-type="bibr">14</xref>], and some studies have confirmed that ROS can also activate the NF-&#x003ba;B pathway to regulate <italic toggle="yes">IL-1&#x003b2;</italic> mRNA transcription [<xref rid="B34-vetsci-11-00643" ref-type="bibr">34</xref>,<xref rid="B35-vetsci-11-00643" ref-type="bibr">35</xref>]. Our data demonstrate that mitochondrial stress can lead to mtROS accumulation in the cytoplasm after the PEDV infection of IPEC-J2 cells. Based on this finding, we speculated that mtROS production after PEDV infection may be involved in NF-&#x003ba;B activation. To test this hypothesis, we explored the role of mtROS in inducing IL-1&#x003b2; production in IPEC-J2 cells infected with PEDV. Western blot experiments showed that P65 and pp65 were upregulated in a dose-dependent manner after PEDV infection (<xref rid="vetsci-11-00643-f006" ref-type="fig">Figure 6</xref>a), indicating that NF-&#x003ba;B was activated. Further, the NF-&#x003ba;B inhibitor, BAY11-7082, significantly inhibited PEDV infection-mediated IL-1&#x003b2; mRNA expression and protein secretion (<xref rid="vetsci-11-00643-f006" ref-type="fig">Figure 6</xref>b,c). Furthermore, Western blotting showed that BAY11-7082 alleviated pp65 phosphorylation and reduced pro-IL-1&#x003b2; protein expression (<xref rid="vetsci-11-00643-f006" ref-type="fig">Figure 6</xref>d). Treating IPEC-J2 cells with the mitochondrial superoxide-targeted inhibitor Mito-TEMPO significantly inhibited <italic toggle="yes">IL-1&#x003b2;</italic> mRNA production mediated by the PEDV infection of IPEC-J2 cells (<xref rid="vetsci-11-00643-f006" ref-type="fig">Figure 6</xref>e,f). These results indicate that mtROS are involved in NF-&#x003ba;B signaling activation after the PEDV infection of IPEC-J2 cells.</p></sec><sec id="sec3dot7-vetsci-11-00643"><title>3.7. PEDV-Infected IPEC-J2 Cells Activate the NLRP3 Inflammasome Through mtDNA Release</title><p>Oxidative stress in mitochondria is an important reason for mtDNA release [<xref rid="B36-vetsci-11-00643" ref-type="bibr">36</xref>]. Further, mtDNA is a recognized DAMP, and mitochondrial oxidative stress can cause mtDNA to translocate into the cytoplasm and activate the NLRP3 inflammasome [<xref rid="B33-vetsci-11-00643" ref-type="bibr">33</xref>,<xref rid="B37-vetsci-11-00643" ref-type="bibr">37</xref>]. To determine whether the mtDNA produced by mitochondrial stress oxidation after the PEDV infection of IPEC-J2 cells is involved in the NLRP3 inflammasome activation process, we next inhibited mtDNA synthesis using DNase I and observed the NLRP3 activation after PEDV infection. The results showed that <italic toggle="yes">IL-1&#x003b2;</italic> mRNA transcription was not affected by DNase I transfection (<xref rid="vetsci-11-00643-f007" ref-type="fig">Figure 7</xref>a); however, it significantly inhibited IL-1&#x003b2; secretion into the cell supernatant (<xref rid="vetsci-11-00643-f007" ref-type="fig">Figure 7</xref>b). In addition, after DNase I transfection, the <italic toggle="yes">NLRP3</italic> inflammasome mRNA expression was reduced in the cells (<xref rid="vetsci-11-00643-f007" ref-type="fig">Figure 7</xref>c), while the caspase-1 enzyme activity decreased (<xref rid="vetsci-11-00643-f007" ref-type="fig">Figure 7</xref>d). The Western blot analysis also showed that the protein expression levels of NLRP3, ASC, caspase-1, and IL-1&#x003b2; were inhibited after DNase I transfection (<xref rid="vetsci-11-00643-f007" ref-type="fig">Figure 7</xref>e). These results indicate that mtDNA activates the NLRP3 inflammasome in PEDV-infected IPEC-J2 cells.</p></sec></sec><sec sec-type="discussion" id="sec4-vetsci-11-00643"><title>4. Discussion</title><p>Since the coronavirus disease 2019 (COVID-19) pandemic, the inflammatory pathogenic mechanisms of coronaviruses have become an important focus of widespread interest worldwide. The new coronavirus mediates IL-1&#x003b2; secretion by activating the NLRP3 inflammasome, leading to a systemic inflammatory storm [<xref rid="B38-vetsci-11-00643" ref-type="bibr">38</xref>]. The porcine enteric coronavirus, transmissible gastroenteritis virus, can also mediate pyroptosis in host cells by activating the NLRP3 inflammasome [<xref rid="B27-vetsci-11-00643" ref-type="bibr">27</xref>]; however, the pathway mediating inflammasome activation during PEDV-induced inflammatory responses has not been completely elucidated. PEDV infection can cause acute enteritis and fatal watery diarrhea in piglets [<xref rid="B15-vetsci-11-00643" ref-type="bibr">15</xref>]. KEGG pathway analysis showed that the inflammatory bowel disease pathway was highly enriched after the co-infection of PK15 cells with PEDV and BVDV [<xref rid="B39-vetsci-11-00643" ref-type="bibr">39</xref>]. Therefore, understanding the detailed molecular mechanisms underlying inflammatory responses may contribute to the prevention and treatment of PEDV infection.</p><p>IL-1&#x003b2; is a pyrogen and an endogenous cell mediator. Numerous studies have proven that PEDV infection can promote inflammatory cytokine secretion and lead to intestinal inflammation [<xref rid="B15-vetsci-11-00643" ref-type="bibr">15</xref>,<xref rid="B25-vetsci-11-00643" ref-type="bibr">25</xref>]. A transcriptome analysis of IPEC-J2 cells infected with PEDV found that the expression of IFN-&#x003b1;, IFN-&#x003b2;, TNF-&#x003b1;, IL-6, IL-8, and IL-12 was increased 12 h after infection, while their levels were not significantly affected during the early stage of infection [<xref rid="B40-vetsci-11-00643" ref-type="bibr">40</xref>]. In this study, we found that PEDV significantly promoted IL-1&#x003b2; secretion during 12 h of IPEC-J2 cell infection and that the levels peaked at 24 h (<xref rid="vetsci-11-00643-f001" ref-type="fig">Figure 1</xref>a), indicating that the process of PEDV&#x02019;s induction of inflammatory factor expression is related to the temporal progression of PEDV infection. Therefore, we speculate that PEDV may inhibit inflammation by producing certain proteins required for its own replication in the early stages of infection and activate innate immune responses in the later stages of infection. This phenomenon is also reflected in the process of SARS-CoV-2 infection, in which the non-structural proteins 1 and 13 can inhibit the NLRP3 inflammasome activation process to meet the early replication needs of the virus [<xref rid="B41-vetsci-11-00643" ref-type="bibr">41</xref>]. Inflammation generation is a double-edged sword: appropriate inflammation induction will activate downstream mechanisms, thereby inhibiting viral replication, while excessive activation will have adverse effects on the host [<xref rid="B42-vetsci-11-00643" ref-type="bibr">42</xref>]. Viruses can regulate inflammation to satisfy their own replication needs; hence, inflammation induction may be related to the PEDV replication mechanism.</p><p>IPEC-J2 cells are porcine intestinal cells that primarily replicate in the small intestines of pigs following infection with PEDV, and they exhibit high sensitivity to the virus [<xref rid="B43-vetsci-11-00643" ref-type="bibr">43</xref>,<xref rid="B44-vetsci-11-00643" ref-type="bibr">44</xref>]; consequently, IPEC-J2 cells were selected as the model for this study. Previous research has demonstrated that the PEDV infection of Vero cells can induce pyroptosis via the NLRP3 inflammasome pathway [<xref rid="B45-vetsci-11-00643" ref-type="bibr">45</xref>], a finding that aligns with the expression trend of the NLRP3 inflammasome observed in IPEC-J2 cells in the present study. Conversely, some studies have indicated that the expression of inflammatory factors is downregulated following PEDV infection. For example, Liu et al. reported that the levels of the NLRP3 inflammasome, p65, and pp65 were downregulated in porcine alveolar macrophages post-infection with PEDV [<xref rid="B46-vetsci-11-00643" ref-type="bibr">46</xref>]. This suggests that PEDV may exert an inhibitory effect on the cellular innate immune inflammatory pathway. Variations in the results across different cell types may be attributable to factors including immune tolerance and viral virulence.</p><p>During IL-1&#x003b2; production, NF-&#x003ba;B regulates <italic toggle="yes">IL-1&#x003b2;</italic> transcription, while the inflammasome mediates IL-1&#x003b2; secretion [<xref rid="B47-vetsci-11-00643" ref-type="bibr">47</xref>,<xref rid="B48-vetsci-11-00643" ref-type="bibr">48</xref>]. Therefore, we studied the specific process involved in the secretion of the inflammatory cytokine IL-1&#x003b2; after the PEDV infection of IPEC-J2 cells, and we found that viral infection activated the NLRP3 inflammasome in this context (<xref rid="vetsci-11-00643-f003" ref-type="fig">Figure 3</xref>). Although we detected an interaction between ASC and the NLRP3 inflammasome protein in the MOCK group using the ASC bait antibody, our results confirm that PEDV infection enhanced the binding of the NLRP3 inflammasome, ASC, and pro-caspase-1 (<xref rid="vetsci-11-00643-f003" ref-type="fig">Figure 3</xref>e,f). After we inhibited the NLRP3 inflammasome, both IL-1&#x003b2; secretion (<xref rid="vetsci-11-00643-f004" ref-type="fig">Figure 4</xref>a,b) and caspase-1 (P20) protein expression (<xref rid="vetsci-11-00643-f004" ref-type="fig">Figure 4</xref>e,f) were reduced. These results indicate that PEDV-infected IPEC-J2 cells secrete IL-1&#x003b2; through the NLRP3 inflammasome pathway. Numerous studies have demonstrated that, after its secretion, IL-1&#x003b2; can activate intracellular NF-KB signaling through IL-1R, to induce positive self-transcriptional regulation [<xref rid="B49-vetsci-11-00643" ref-type="bibr">49</xref>,<xref rid="B50-vetsci-11-00643" ref-type="bibr">50</xref>,<xref rid="B51-vetsci-11-00643" ref-type="bibr">51</xref>]. We found that the NF-KB signaling pathway was activated after PEDV infection (<xref rid="vetsci-11-00643-f006" ref-type="fig">Figure 6</xref>a), and we speculate that, after PEDV infects IPEC-J2 cells, it may also mediate NF-KB signaling pathway activation through the IL-1&#x003b2; paracrine pathway, thus aggravating the inflammatory process. Further, NF-KB signaling activation can mediate myosin light chain kinase secretion and affect tight junction proteins, resulting in increased intestinal permeability and diarrhea [<xref rid="B52-vetsci-11-00643" ref-type="bibr">52</xref>,<xref rid="B53-vetsci-11-00643" ref-type="bibr">53</xref>]. We speculate that the PEDV infection process may be related to the above pathways. The detailed mechanisms underlying PEDV-mediated inflammatory diarrhea warrant further study.</p><p>Mitochondria are not only the main source of ATP but also participate in many other cell signaling events, such as the regulation of Ca<sup>2+</sup> homeostasis, apoptosis, and ROS production [<xref rid="B54-vetsci-11-00643" ref-type="bibr">54</xref>]. mtROS production is essentially a physiological response to resist pathogenic invasion, which is beneficial in inhibiting the viral infection process. mtROS clearance increases the viral titer in nasal epithelial cells upon infection with influenza A virus [<xref rid="B55-vetsci-11-00643" ref-type="bibr">55</xref>]. Further, mtROS can amplify mitochondrial antiviral signaling and RIG-I-like receptor-mediated antiviral responses [<xref rid="B56-vetsci-11-00643" ref-type="bibr">56</xref>]; however, excessive mtROS production can mediate inflammatory reactions and cause physiological damage [<xref rid="B57-vetsci-11-00643" ref-type="bibr">57</xref>]. This has also been confirmed during SARS-CoV-2 infection. The mtROS content produced by infected human alveolar epithelial cells is markedly increased compared with extracellular ROS production, prolonging oxidative stress and exacerbating inflammation [<xref rid="B58-vetsci-11-00643" ref-type="bibr">58</xref>]. We detected mtROS production after the PEDV infection of IPEC-J2 cells by flow cytometry and found that mtROS were also highly accumulated in the cytoplasm of IPEC-J2 cells (<xref rid="vetsci-11-00643-f005" ref-type="fig">Figure 5</xref>c). Further, treating the cells with mtROS inhibitors significantly inhibited IL-1&#x003b2; mRNA transcription and protein secretion in the cell supernatants (<xref rid="vetsci-11-00643-f006" ref-type="fig">Figure 6</xref>e). This finding indicates that mtROS may act as an agonist to increase IL-1&#x003b2; production during IL-1&#x003b2; generation by PEDV-infected IPEC-J2 cells.</p><p>mtDNA is present in mitochondria and, after release, acts as a DAMP, thereby mediating cellular inflammatory responses [<xref rid="B59-vetsci-11-00643" ref-type="bibr">59</xref>]. Many viral infections can induce host cells to produce immune responses through mtDNA; for example, HIV can exert inflammatory effects by increasing plasma mtDNA [<xref rid="B60-vetsci-11-00643" ref-type="bibr">60</xref>]. Further, DENV can induce mtDNA release in the cytoplasm, upregulate TLR9, and influence downstream signaling events [<xref rid="B19-vetsci-11-00643" ref-type="bibr">19</xref>], while PRRSV activates the NLRP3 inflammasome through cytoplasmic mtDNA stress [<xref rid="B20-vetsci-11-00643" ref-type="bibr">20</xref>]. Interestingly, we also observed similar results in PEDV-infected IPEC-J2 cells. By detecting the localization of mitochondria and mtDNA, we found that mtDNA was released into the cytoplasm after PEDV infection (<xref rid="vetsci-11-00643-f005" ref-type="fig">Figure 5</xref>d) and activated the NLRP3 inflammasome in IPEC-J2 cells (<xref rid="vetsci-11-00643-f007" ref-type="fig">Figure 7</xref>e). mtDNA release is related to mitochondrial dysfunction, and the released mtDNA can directly bind to pattern recognition receptors and inflammasomes to enhance pro-inflammatory responses [<xref rid="B61-vetsci-11-00643" ref-type="bibr">61</xref>].</p></sec><sec sec-type="conclusions" id="sec5-vetsci-11-00643"><title>5. Conclusions</title><p>In conclusion, we observed that the PEDV infection of IPEC-J2 cells caused mitochondrial dysfunction, mtROS production, and mtDNA release, to activate the NF-&#x003ba;B signaling pathway and NLRP3 inflammasome, thereby inducing IL-1&#x003b2; production. We report, for the first time, that the NLRP3 inflammasome is activated after the PEDV infection of IPEC-J2 cells, mediating IL-1&#x003b2; secretion. Our data also indicate that mitochondria are critical in PEDV-triggered inflammatory responses (<xref rid="vetsci-11-00643-f008" ref-type="fig">Figure 8</xref>). The results of this research enrich our understanding of the inflammatory mechanisms occurring during PEDV infection and provide new ideas to inform the development of anti-PEDV-targeted drugs.</p></sec></body><back><ack><title>Acknowledgments</title><p>We would like to thank Laboratory 214 of the College of Veterinary Medicine of Jilin Agricultural University, Jilin Agricultural Science and Technology University, and Jilin Academy of Agricultural Sciences for providing the experimental platform and technical support.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-vetsci-11-00643"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/vetsci11120643/s1">https://www.mdpi.com/article/10.3390/vetsci11120643/s1</uri>. The original Western blots will be published as Supplementary Materials.</p><supplementary-material id="vetsci-11-00643-s001" position="float" content-type="local-data"><media xlink:href="vetsci-11-00643-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>D.B.: Conceptualization, Validation, Formal Analysis, Resources, Data Curation, Writing&#x02014;Original Draft Preparation, Writing&#x02014;Review And Editing, Funding Acquisition; S.Y.: Conceptualization, Data Curation, Writing&#x02014;Review and Editing; L.Z.: Conceptualization, Validation, Formal Analysis, Resources, Data Curation, Writing&#x02014;Original Draft Preparation, Writing&#x02014;Review and Editing, Funding Acquisition; G.H.: Formal Analysis, Resources, Writing&#x02014;Review and Editing, Funding Acquisition; X.L.: Resources, Writing&#x02014;Review and Editing, Funding Acquisition; H.Z.: Writing&#x02014;Review and Editing; J.L.: Writing&#x02014;Review and Editing; Y.W.: Writing&#x02014;Review and Editing. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The original contributions presented in the study are included in the article/<xref rid="app1-vetsci-11-00643" ref-type="app">Supplementary Materials</xref>, further inquiries can be directed to the corresponding author.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-vetsci-11-00643"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yu</surname><given-names>L.</given-names></name>
<name><surname>Dong</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>P.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>Liang</surname><given-names>P.</given-names></name>
<name><surname>Wang</surname><given-names>L.</given-names></name>
<name><surname>Song</surname><given-names>C.</given-names></name>
</person-group><article-title>Porcine epidemic diarrhea virus nsp4 induces pro-inflammatory cytokine and chemokine expression inhibiting viral replication in vitro</article-title><source>Arch. Virol.</source><year>2019</year><volume>164</volume><fpage>1147</fpage><lpage>1157</lpage><pub-id pub-id-type="doi">10.1007/s00705-019-04176-2</pub-id><pub-id pub-id-type="pmid">30799511</pub-id>
</element-citation></ref><ref id="B2-vetsci-11-00643"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
<name><surname>Dong</surname><given-names>J.</given-names></name>
<name><surname>Liang</surname><given-names>Y.</given-names></name>
<name><surname>Huang</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>H.J.</given-names></name>
<name><surname>Tong</surname><given-names>D.</given-names></name>
</person-group><article-title>Porcine epidemic diarrhea virus E protein causes endoplasmic reticulum stress and up-regulates interleukin-8 expression</article-title><source>Virol. J.</source><year>2013</year><volume>10</volume><fpage>26</fpage><pub-id pub-id-type="doi">10.1186/1743-422X-10-26</pub-id><pub-id pub-id-type="pmid">23332027</pub-id>
</element-citation></ref><ref id="B3-vetsci-11-00643"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jung</surname><given-names>K.</given-names></name>
<name><surname>Miyazaki</surname><given-names>A.</given-names></name>
<name><surname>Saif</surname><given-names>L.J.</given-names></name>
</person-group><article-title>Immunohistochemical detection of the vomiting-inducing monoamine neurotransmitter serotonin and enterochromaffin cells in the intestines of conventional or gnotobiotic (Gn) pigs infected with porcine epidemic diarrhea virus (PEDV) and serum cytokine responses of Gn pigs to acute PEDV infection</article-title><source>Res. Vet. Sci.</source><year>2018</year><volume>119</volume><fpage>99</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">29909130</pub-id>
</element-citation></ref><ref id="B4-vetsci-11-00643"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sundaram</surname><given-names>B.</given-names></name>
<name><surname>Tweedell</surname><given-names>R.E.</given-names></name>
<name><surname>Prasanth Kumar</surname><given-names>S.P.</given-names></name>
<name><surname>Kanneganti</surname><given-names>T.-D.</given-names></name>
</person-group><article-title>The NLR family of innate immune and cell death sensors</article-title><source>Immunity</source><year>2024</year><volume>57</volume><fpage>674</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2024.03.012</pub-id><pub-id pub-id-type="pmid">38599165</pub-id>
</element-citation></ref><ref id="B5-vetsci-11-00643"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>A.</given-names></name>
<name><surname>Wu</surname><given-names>H.</given-names></name>
</person-group><article-title>Structural mechanisms of inflammasome assembly</article-title><source>FEBS J.</source><year>2015</year><volume>282</volume><fpage>435</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1111/febs.13133</pub-id><pub-id pub-id-type="pmid">25354325</pub-id>
</element-citation></ref><ref id="B6-vetsci-11-00643"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bae</surname><given-names>J.Y.</given-names></name>
<name><surname>Park</surname><given-names>H.H.</given-names></name>
</person-group><article-title>Crystal structure of NALP3 protein pyrin domain (PYD) and its implications in inflammasome assembly</article-title><source>J. Biol. Chem.</source><year>2011</year><volume>286</volume><fpage>39528</fpage><lpage>39536</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.278812</pub-id><pub-id pub-id-type="pmid">21880711</pub-id>
</element-citation></ref><ref id="B7-vetsci-11-00643"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rathinam</surname><given-names>V.A.</given-names></name>
<name><surname>Fitzgerald</surname><given-names>K.A.</given-names></name>
</person-group><article-title>Inflammasome complexes: Emerging mechanisms and effector functions</article-title><source>Cell</source><year>2016</year><volume>165</volume><fpage>792</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.03.046</pub-id><pub-id pub-id-type="pmid">27153493</pub-id>
</element-citation></ref><ref id="B8-vetsci-11-00643"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pandey</surname><given-names>A.</given-names></name>
<name><surname>Shen</surname><given-names>C.</given-names></name>
<name><surname>Feng</surname><given-names>S.</given-names></name>
<name><surname>Man</surname><given-names>S.M.</given-names></name>
</person-group><article-title>Cell biology of inflammasome activation</article-title><source>Trends Cell Biol.</source><year>2021</year><volume>31</volume><fpage>924</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2021.06.010</pub-id><pub-id pub-id-type="pmid">34284921</pub-id>
</element-citation></ref><ref id="B9-vetsci-11-00643"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nakano</surname><given-names>R.</given-names></name>
<name><surname>Kitanaka</surname><given-names>T.</given-names></name>
<name><surname>Namba</surname><given-names>S.</given-names></name>
<name><surname>Kitanaka</surname><given-names>N.</given-names></name>
<name><surname>Suwabe</surname><given-names>Y.</given-names></name>
<name><surname>Konno</surname><given-names>T.</given-names></name>
<name><surname>Yamazaki</surname><given-names>J.</given-names></name>
<name><surname>Nakayama</surname><given-names>T.</given-names></name>
<name><surname>Sugiya</surname><given-names>H.</given-names></name>
</person-group><article-title>Non-transcriptional and translational function of canonical NF-kB signaling in activating ERK1/2, in IL-1&#x003b2;-induced COX-2 expression in synovial fibroblasts</article-title><source>Front. Immunol.</source><year>2020</year><volume>11</volume><elocation-id>579266</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.579266</pub-id><pub-id pub-id-type="pmid">33117381</pub-id>
</element-citation></ref><ref id="B10-vetsci-11-00643"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Newton</surname><given-names>R.</given-names></name>
<name><surname>Kuitert</surname><given-names>L.M.</given-names></name>
<name><surname>Bergmann</surname><given-names>M.</given-names></name>
<name><surname>Adcock</surname><given-names>I.M.</given-names></name>
<name><surname>Barnes</surname><given-names>P.J.</given-names></name>
</person-group><article-title>Evidence for involvement of NF-&#x003ba;B in the transcriptional control of COX-2 gene expression by IL-1&#x003b2;</article-title><source>Biochem. Biophys. Res. Commun.</source><year>1997</year><volume>237</volume><fpage>28</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1997.7064</pub-id><pub-id pub-id-type="pmid">9266823</pub-id>
</element-citation></ref><ref id="B11-vetsci-11-00643"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Anilkumar</surname><given-names>S.</given-names></name>
<name><surname>Wright-Jin</surname><given-names>E.</given-names></name>
</person-group><article-title>NF-&#x003ba;B as an inducible regulator of inflammation in the central nervous system</article-title><source>Cells</source><year>2024</year><volume>13</volume><elocation-id>485</elocation-id><pub-id pub-id-type="doi">10.3390/cells13060485</pub-id><pub-id pub-id-type="pmid">38534329</pub-id>
</element-citation></ref><ref id="B12-vetsci-11-00643"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fu</surname><given-names>J.</given-names></name>
<name><surname>Schroder</surname><given-names>K.</given-names></name>
<name><surname>Wu</surname><given-names>H.</given-names></name>
</person-group><article-title>Mechanistic insights from inflammasome structures</article-title><source>Nat. Rev. Immunol.</source><year>2024</year><volume>24</volume><fpage>518</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1038/s41577-024-00995-w</pub-id><pub-id pub-id-type="pmid">38374299</pub-id>
</element-citation></ref><ref id="B13-vetsci-11-00643"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lupfer</surname><given-names>C.</given-names></name>
<name><surname>Malik</surname><given-names>A.</given-names></name>
<name><surname>Kanneganti</surname><given-names>T.-D.</given-names></name>
</person-group><article-title>Inflammasome control of viral infection</article-title><source>Curr. Opin. Virol.</source><year>2015</year><volume>12</volume><fpage>38</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.coviro.2015.02.007</pub-id><pub-id pub-id-type="pmid">25771504</pub-id>
</element-citation></ref><ref id="B14-vetsci-11-00643"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cao</surname><given-names>L.</given-names></name>
<name><surname>Ge</surname><given-names>X.</given-names></name>
<name><surname>Gao</surname><given-names>Y.</given-names></name>
<name><surname>Ren</surname><given-names>Y.</given-names></name>
<name><surname>Ren</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>G.</given-names></name>
</person-group><article-title>Porcine epidemic diarrhea virus infection induces NF-&#x003ba;B activation through the TLR2, TLR3 and TLR9 pathways in porcine intestinal epithelial cells</article-title><source>J. Gen. Virol.</source><year>2015</year><volume>96</volume><fpage>1757</fpage><lpage>1767</lpage><pub-id pub-id-type="doi">10.1099/vir.0.000133</pub-id><pub-id pub-id-type="pmid">25814121</pub-id>
</element-citation></ref><ref id="B15-vetsci-11-00643"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>P.</given-names></name>
<name><surname>Fahd</surname><given-names>Q.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Sun</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Qaria</surname><given-names>M.A.</given-names></name>
<name><surname>He</surname><given-names>Z.S.</given-names></name>
<name><surname>Fan</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
<name><surname>Xu</surname><given-names>Q.</given-names></name>
<etal/>
</person-group><article-title>Transcriptomic analysis of small intestinal mucosa from porcine epidemic diarrhea virus infected piglets</article-title><source>Microb. Pathog.</source><year>2019</year><volume>132</volume><fpage>73</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2019.04.033</pub-id><pub-id pub-id-type="pmid">31026494</pub-id>
</element-citation></ref><ref id="B16-vetsci-11-00643"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arnoult</surname><given-names>D.</given-names></name>
<name><surname>Soares</surname><given-names>F.</given-names></name>
<name><surname>Tattoli</surname><given-names>I.</given-names></name>
<name><surname>Girardin</surname><given-names>S.E.</given-names></name>
</person-group><article-title>Mitochondria in innate immunity</article-title><source>EMBO Rep.</source><year>2011</year><volume>12</volume><fpage>901</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1038/embor.2011.157</pub-id><pub-id pub-id-type="pmid">21799518</pub-id>
</element-citation></ref><ref id="B17-vetsci-11-00643"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>West</surname><given-names>A.P.</given-names></name>
<name><surname>Shadel</surname><given-names>G.S.</given-names></name>
<name><surname>Ghosh</surname><given-names>S.</given-names></name>
</person-group><article-title>Mitochondria in innate immune responses</article-title><source>Nat. Rev. Immunol.</source><year>2011</year><volume>11</volume><fpage>389</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1038/nri2975</pub-id><pub-id pub-id-type="pmid">21597473</pub-id>
</element-citation></ref><ref id="B18-vetsci-11-00643"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Banoth</surname><given-names>B.</given-names></name>
<name><surname>Cassel</surname><given-names>S.L.</given-names></name>
</person-group><article-title>Mitochondria in innate immune signaling</article-title><source>Transl. Res.</source><year>2018</year><volume>202</volume><fpage>52</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/j.trsl.2018.07.014</pub-id><pub-id pub-id-type="pmid">30165038</pub-id>
</element-citation></ref><ref id="B19-vetsci-11-00643"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lai</surname><given-names>J.H.</given-names></name>
<name><surname>Wang</surname><given-names>M.Y.</given-names></name>
<name><surname>Huang</surname><given-names>C.Y.</given-names></name>
<name><surname>Wu</surname><given-names>C.H.</given-names></name>
<name><surname>Hung</surname><given-names>L.F.</given-names></name>
<name><surname>Yang</surname><given-names>C.Y.</given-names></name>
<name><surname>Ke</surname><given-names>P.Y.</given-names></name>
<name><surname>Luo</surname><given-names>S.F.</given-names></name>
<name><surname>Liu</surname><given-names>S.J.</given-names></name>
<name><surname>Ho</surname><given-names>L.J.</given-names></name>
</person-group><article-title>Infection with the dengue RNA virus activates TLR9 signaling in human dendritic cells</article-title><source>EMBO Rep.</source><year>2018</year><volume>19</volume><fpage>e46182</fpage><pub-id pub-id-type="doi">10.15252/embr.201846182</pub-id><pub-id pub-id-type="pmid">29880709</pub-id>
</element-citation></ref><ref id="B20-vetsci-11-00643"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>H.</given-names></name>
<name><surname>Yang</surname><given-names>X.</given-names></name>
<name><surname>Song</surname><given-names>Y.</given-names></name>
<name><surname>Zhu</surname><given-names>Q.</given-names></name>
<name><surname>Liao</surname><given-names>Z.</given-names></name>
<name><surname>Liang</surname><given-names>Y.</given-names></name>
<name><surname>Guo</surname><given-names>J.</given-names></name>
<name><surname>Wan</surname><given-names>B.</given-names></name>
<name><surname>Bao</surname><given-names>D.</given-names></name>
</person-group><article-title>PRRSV infection activates NLRP3 inflammasome through inducing cytosolic mitochondrial DNA stress</article-title><source>Vet. Microbiol.</source><year>2023</year><volume>279</volume><elocation-id>109673</elocation-id><pub-id pub-id-type="doi">10.1016/j.vetmic.2023.109673</pub-id><pub-id pub-id-type="pmid">36764219</pub-id>
</element-citation></ref><ref id="B21-vetsci-11-00643"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moriyama</surname><given-names>M.</given-names></name>
<name><surname>Koshiba</surname><given-names>T.</given-names></name>
<name><surname>Ichinohe</surname><given-names>T.</given-names></name>
</person-group><article-title>Influenza A virus M2 protein triggers mitochondrial DNA-mediated antiviral immune responses</article-title><source>Nat. Commun.</source><year>2019</year><volume>10</volume><fpage>4624</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-12632-5</pub-id><pub-id pub-id-type="pmid">31604929</pub-id>
</element-citation></ref><ref id="B22-vetsci-11-00643"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liang</surname><given-names>R.</given-names></name>
<name><surname>Song</surname><given-names>H.</given-names></name>
<name><surname>Wang</surname><given-names>K.</given-names></name>
<name><surname>Ding</surname><given-names>F.</given-names></name>
<name><surname>Xuan</surname><given-names>D.</given-names></name>
<name><surname>Miao</surname><given-names>J.</given-names></name>
<name><surname>Fei</surname><given-names>R.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
</person-group><article-title>Porcine epidemic diarrhea virus 3CLpro causes apoptosis and collapse of mitochondrial membrane potential requiring its protease activity and signaling through MAVS</article-title><source>Vet. Microbiol.</source><year>2022</year><volume>275</volume><elocation-id>109596</elocation-id><pub-id pub-id-type="doi">10.1016/j.vetmic.2022.109596</pub-id><pub-id pub-id-type="pmid">36335841</pub-id>
</element-citation></ref><ref id="B23-vetsci-11-00643"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Caucheteux</surname><given-names>S.M.</given-names></name>
<name><surname>Hu-Li</surname><given-names>J.</given-names></name>
<name><surname>Guo</surname><given-names>L.</given-names></name>
<name><surname>Bhattacharyya</surname><given-names>N.</given-names></name>
<name><surname>Crank</surname><given-names>M.</given-names></name>
<name><surname>Collins</surname><given-names>M.T.</given-names></name>
<name><surname>Paul</surname><given-names>W.E.</given-names></name>
</person-group><article-title>IL-1&#x003b2; enhances inflammatory TH2 differentiation</article-title><source>J. Allergy Clin. Immunol.</source><year>2016</year><volume>138</volume><fpage>898</fpage><lpage>901.e4</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2016.02.033</pub-id><pub-id pub-id-type="pmid">27212084</pub-id>
</element-citation></ref><ref id="B24-vetsci-11-00643"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tricarico</surname><given-names>P.M.</given-names></name>
<name><surname>Epate</surname><given-names>A.</given-names></name>
<name><surname>Celsi</surname><given-names>F.</given-names></name>
<name><surname>Crovella</surname><given-names>S.</given-names></name>
</person-group><article-title>Alendronate treatment induces IL-1B expression and apoptosis in glioblastoma cell line</article-title><source>Inflammopharmacology</source><year>2018</year><volume>26</volume><fpage>285</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1007/s10787-017-0369-5</pub-id><pub-id pub-id-type="pmid">28646347</pub-id>
</element-citation></ref><ref id="B25-vetsci-11-00643"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>J.</given-names></name>
<name><surname>Cui</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>Z.</given-names></name>
<name><surname>Liu</surname><given-names>G.</given-names></name>
</person-group><article-title>Identification and characterization of PEDV infection in rat crypt epithelial cells</article-title><source>Vet. Microbiol.</source><year>2020</year><volume>249</volume><elocation-id>108848</elocation-id><pub-id pub-id-type="doi">10.1016/j.vetmic.2020.108848</pub-id><pub-id pub-id-type="pmid">32979749</pub-id>
</element-citation></ref><ref id="B26-vetsci-11-00643"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yuan</surname><given-names>J.</given-names></name>
<name><surname>Najafov</surname><given-names>A.</given-names></name>
<name><surname>Py</surname><given-names>B.F.</given-names></name>
</person-group><article-title>Roles of caspases in necrotic cell death</article-title><source>Cell</source><year>2016</year><volume>167</volume><fpage>1693</fpage><lpage>1704</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.11.047</pub-id><pub-id pub-id-type="pmid">27984721</pub-id>
</element-citation></ref><ref id="B27-vetsci-11-00643"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wei</surname><given-names>G.</given-names></name>
<name><surname>Luo</surname><given-names>S.</given-names></name>
<name><surname>Wu</surname><given-names>W.</given-names></name>
<name><surname>Hu</surname><given-names>J.</given-names></name>
<name><surname>Zhou</surname><given-names>R.</given-names></name>
</person-group><article-title>Activation of interleukin-1&#x003b2; release and pyroptosis by transmissible gastroenteritis virus is dependent on the NOD-like receptor Protein 3 inflammasome in porcine intestinal epithelial cell line</article-title><source>Viral Immunol.</source><year>2021</year><volume>34</volume><fpage>401</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1089/vim.2020.0227</pub-id><pub-id pub-id-type="pmid">33973805</pub-id>
</element-citation></ref><ref id="B28-vetsci-11-00643"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>He</surname><given-names>S.</given-names></name>
<name><surname>Li</surname><given-names>L.</given-names></name>
<name><surname>Chen</surname><given-names>H.</given-names></name>
<name><surname>Hu</surname><given-names>X.</given-names></name>
<name><surname>Wang</surname><given-names>W.</given-names></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
<name><surname>Wei</surname><given-names>R.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
</person-group><article-title>PRRSV infection induces gasdermin D-driven pyroptosis of porcine alveolar macrophages through NLRP3 inflammasome activation</article-title><source>J. Virol.</source><year>2022</year><volume>96</volume><fpage>e0212721</fpage><pub-id pub-id-type="doi">10.1128/jvi.02127-21</pub-id><pub-id pub-id-type="pmid">35758658</pub-id>
</element-citation></ref><ref id="B29-vetsci-11-00643"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ji</surname><given-names>S.</given-names></name>
<name><surname>Dai</surname><given-names>M.-Y.</given-names></name>
<name><surname>Huang</surname><given-names>Y.</given-names></name>
<name><surname>Ren</surname><given-names>X.-C.</given-names></name>
<name><surname>Jiang</surname><given-names>M.-L.</given-names></name>
<name><surname>Qiao</surname><given-names>J.-P.</given-names></name>
<name><surname>Zhang</surname><given-names>W.-Y.</given-names></name>
<name><surname>Xu</surname><given-names>Y.-H.</given-names></name>
<name><surname>Shen</surname><given-names>J.-L.</given-names></name>
<name><surname>Zhang</surname><given-names>R.-Q.</given-names></name>
<etal/>
</person-group><article-title>Influenza A virus triggers acute exacerbation of chronic obstructive pulmonary disease by increasing proinflammatory cytokines secretion via NLRP3 inflammasome activation</article-title><source>J. Inflamm.</source><year>2022</year><volume>19</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.1186/s12950-022-00305-y</pub-id></element-citation></ref><ref id="B30-vetsci-11-00643"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Angajala</surname><given-names>A.</given-names></name>
<name><surname>Lim</surname><given-names>S.</given-names></name>
<name><surname>Phillips</surname><given-names>J.B.</given-names></name>
<name><surname>Kim</surname><given-names>J.-H.</given-names></name>
<name><surname>Yates</surname><given-names>C.</given-names></name>
<name><surname>You</surname><given-names>Z.</given-names></name>
<name><surname>Tan</surname><given-names>M.</given-names></name>
</person-group><article-title>Diverse roles of mitochondria in immune responses: Novel insights into immuno-metabolism</article-title><source>Front. Immunol.</source><year>2018</year><volume>9</volume><elocation-id>1605</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.01605</pub-id><pub-id pub-id-type="pmid">30050539</pub-id>
</element-citation></ref><ref id="B31-vetsci-11-00643"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sho</surname><given-names>T.</given-names></name>
<name><surname>Xu</surname><given-names>J.</given-names></name>
</person-group><article-title>Role and mechanism of ROS scavengers in alleviating NLRP3-mediated inflammation</article-title><source>Biotechnol. Appl. Biochem.</source><year>2019</year><volume>66</volume><fpage>4</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1002/bab.1700</pub-id><pub-id pub-id-type="pmid">30315709</pub-id>
</element-citation></ref><ref id="B32-vetsci-11-00643"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liao</surname><given-names>S.</given-names></name>
<name><surname>Chen</surname><given-names>L.</given-names></name>
<name><surname>Song</surname><given-names>Z.</given-names></name>
<name><surname>He</surname><given-names>H.</given-names></name>
</person-group><article-title>The fate of damaged mitochondrial DNA in the cell</article-title><source>Biochim. Biophys. Acta Mol. Cell Res.</source><year>2022</year><volume>1869</volume><elocation-id>119233</elocation-id><pub-id pub-id-type="doi">10.1016/j.bbamcr.2022.119233</pub-id><pub-id pub-id-type="pmid">35131372</pub-id>
</element-citation></ref><ref id="B33-vetsci-11-00643"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qiu</surname><given-names>Y.</given-names></name>
<name><surname>Huang</surname><given-names>Y.</given-names></name>
<name><surname>Chen</surname><given-names>M.</given-names></name>
<name><surname>Yang</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
</person-group><article-title>Mitochondrial DNA in NLRP3 inflammasome activation</article-title><source>Int. Immunopharmacol.</source><year>2022</year><volume>108</volume><fpage>108719</fpage><pub-id pub-id-type="doi">10.1016/j.intimp.2022.108719</pub-id><pub-id pub-id-type="pmid">35349960</pub-id>
</element-citation></ref><ref id="B34-vetsci-11-00643"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Patergnani</surname><given-names>S.</given-names></name>
<name><surname>Bouhamida</surname><given-names>E.</given-names></name>
<name><surname>Leo</surname><given-names>S.</given-names></name>
<name><surname>Pinton</surname><given-names>P.</given-names></name>
<name><surname>Rimessi</surname><given-names>A.</given-names></name>
</person-group><article-title>Mitochondrial oxidative stress and &#x02018;mito-inflammation&#x02019;: Actors in the diseases</article-title><source>Biomedicines</source><year>2021</year><volume>9</volume><elocation-id>216</elocation-id><pub-id pub-id-type="doi">10.3390/biomedicines9020216</pub-id><pub-id pub-id-type="pmid">33672477</pub-id>
</element-citation></ref><ref id="B35-vetsci-11-00643"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lingappan</surname><given-names>K.</given-names></name>
</person-group><article-title>NF-&#x003ba;B in oxidative stress</article-title><source>Curr. Opin. Toxicol.</source><year>2018</year><volume>7</volume><fpage>81</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.cotox.2017.11.002</pub-id><pub-id pub-id-type="pmid">29862377</pub-id>
</element-citation></ref><ref id="B36-vetsci-11-00643"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kang</surname><given-names>D.</given-names></name>
<name><surname>Hamasaki</surname><given-names>N.</given-names></name>
</person-group><article-title>Mitochondrial oxidative stress and mitochondrial DNA</article-title><source>Clin. Chem. Lab. Med.</source><year>2003</year><volume>41</volume><fpage>1281</fpage><lpage>1288</lpage><pub-id pub-id-type="doi">10.1515/CCLM.2003.195</pub-id><pub-id pub-id-type="pmid">14580153</pub-id>
</element-citation></ref><ref id="B37-vetsci-11-00643"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Newman</surname><given-names>L.E.</given-names></name>
<name><surname>Shadel</surname><given-names>G.S.</given-names></name>
</person-group><article-title>Mitochondrial DNA release in innate immune signaling</article-title><source>Annu. Rev. Biochem.</source><year>2023</year><volume>92</volume><fpage>299</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1146/annurev-biochem-032620-104401</pub-id><pub-id pub-id-type="pmid">37001140</pub-id>
</element-citation></ref><ref id="B38-vetsci-11-00643"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pan</surname><given-names>P.</given-names></name>
<name><surname>Shen</surname><given-names>M.</given-names></name>
<name><surname>Yu</surname><given-names>Z.</given-names></name>
<name><surname>Ge</surname><given-names>W.</given-names></name>
<name><surname>Chen</surname><given-names>K.</given-names></name>
<name><surname>Tian</surname><given-names>M.</given-names></name>
<name><surname>Xiao</surname><given-names>F.</given-names></name>
<name><surname>Wang</surname><given-names>Z.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Jia</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title>SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation</article-title><source>Nat. Commun.</source><year>2021</year><volume>12</volume><fpage>4664</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-25015-6</pub-id><pub-id pub-id-type="pmid">34341353</pub-id>
</element-citation></ref><ref id="B39-vetsci-11-00643"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cheng</surname><given-names>J.</given-names></name>
<name><surname>Tao</surname><given-names>J.</given-names></name>
<name><surname>Li</surname><given-names>B.</given-names></name>
<name><surname>Shi</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>H.</given-names></name>
</person-group><article-title>Coinfection with PEDV and BVDV induces inflammatory bowel disease pathway highly enriched in PK-15 cells</article-title><source>Virol. J.</source><year>2022</year><volume>19</volume><fpage>119</fpage><pub-id pub-id-type="doi">10.1186/s12985-022-01845-8</pub-id><pub-id pub-id-type="pmid">35842726</pub-id>
</element-citation></ref><ref id="B40-vetsci-11-00643"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>S.</given-names></name>
<name><surname>Wu</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>F.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Wu</surname><given-names>Z.</given-names></name>
<name><surname>Wu</surname><given-names>S.</given-names></name>
<name><surname>Bao</surname><given-names>W.</given-names></name>
</person-group><article-title>Expression pattern analysis of antiviral genes and inflammatory cytokines in PEDV-infected porcine intestinal epithelial cells</article-title><source>Front. Vet. Sci.</source><year>2020</year><volume>7</volume><elocation-id>75</elocation-id><pub-id pub-id-type="doi">10.3389/fvets.2020.00075</pub-id><pub-id pub-id-type="pmid">32133381</pub-id>
</element-citation></ref><ref id="B41-vetsci-11-00643"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>N.-E.</given-names></name>
<name><surname>Kim</surname><given-names>D.-K.</given-names></name>
<name><surname>Song</surname><given-names>Y.-J.</given-names></name>
</person-group><article-title>SARS-CoV-2 nonstructural proteins 1 and 13 suppress caspase-1 and the NLRP3 inflammasome activation</article-title><source>Microorganisms</source><year>2021</year><volume>9</volume><elocation-id>494</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms9030494</pub-id><pub-id pub-id-type="pmid">33652815</pub-id>
</element-citation></ref><ref id="B42-vetsci-11-00643"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tan</surname><given-names>L.Y.</given-names></name>
<name><surname>Komarasamy</surname><given-names>T.V.</given-names></name>
<name><surname>Rmt Balasubramaniam</surname><given-names>V.</given-names></name>
</person-group><article-title>Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword</article-title><source>Front. Immunol.</source><year>2021</year><volume>12</volume><elocation-id>742941</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2021.742941</pub-id><pub-id pub-id-type="pmid">34659238</pub-id>
</element-citation></ref><ref id="B43-vetsci-11-00643"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>X.-Y.</given-names></name>
<name><surname>Zhao</surname><given-names>T.-Q.</given-names></name>
<name><surname>Xu</surname><given-names>D.-P.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>Ji</surname><given-names>C.-J.</given-names></name>
<name><surname>Zhang</surname><given-names>D.-L.</given-names></name>
</person-group><article-title>The influence of porcine epidemic diarrhea virus on pig small intestine mucosal epithelial cell function</article-title><source>Arch. Virol.</source><year>2019</year><volume>164</volume><fpage>83</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1007/s00705-018-4061-x</pub-id><pub-id pub-id-type="pmid">30284628</pub-id>
</element-citation></ref><ref id="B44-vetsci-11-00643"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brosnahan</surname><given-names>A.J.</given-names></name>
<name><surname>Brown</surname><given-names>D.R.</given-names></name>
</person-group><article-title>Porcine IPEC-J2 intestinal epithelial cells in microbiological investigations</article-title><source>Vet. Microbiol.</source><year>2012</year><volume>156</volume><fpage>229</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2011.10.017</pub-id><pub-id pub-id-type="pmid">22074860</pub-id>
</element-citation></ref><ref id="B45-vetsci-11-00643"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Yang</surname><given-names>S.</given-names></name>
<name><surname>Yin</surname><given-names>B.</given-names></name>
<name><surname>Zhao</surname><given-names>Z.</given-names></name>
<name><surname>Huang</surname><given-names>Z.</given-names></name>
<name><surname>Wu</surname><given-names>J.</given-names></name>
<name><surname>Lin</surname><given-names>S.</given-names></name>
<name><surname>Wang</surname><given-names>X.</given-names></name>
</person-group><article-title>Water extract of Portulaca oleracea inhibits PEDV infection-induced pyrolysis by caspase-1/GSDMD</article-title><source>Curr. Issues Mol. Biol.</source><year>2023</year><volume>45</volume><fpage>10211</fpage><lpage>10224</lpage><pub-id pub-id-type="doi">10.3390/cimb45120637</pub-id><pub-id pub-id-type="pmid">38132483</pub-id>
</element-citation></ref><ref id="B46-vetsci-11-00643"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>D.</given-names></name>
<name><surname>Wang</surname><given-names>Q.</given-names></name>
<name><surname>He</surname><given-names>W.</given-names></name>
<name><surname>Ge</surname><given-names>L.</given-names></name>
<name><surname>Huang</surname><given-names>K.</given-names></name>
</person-group><article-title>Deoxynivalenol aggravates the immunosuppression in piglets and PAMs under the condition of PEDV infection through inhibiting TLR4/NLRP3 signaling pathway</article-title><source>Ecotoxicol. Environ. Saf.</source><year>2022</year><volume>231</volume><fpage>113209</fpage><pub-id pub-id-type="doi">10.1016/j.ecoenv.2022.113209</pub-id><pub-id pub-id-type="pmid">35051765</pub-id>
</element-citation></ref><ref id="B47-vetsci-11-00643"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rubartelli</surname><given-names>A.</given-names></name>
<name><surname>Bajetto</surname><given-names>A.</given-names></name>
<name><surname>Allavena</surname><given-names>G.</given-names></name>
<name><surname>Cozzolino</surname><given-names>F.</given-names></name>
<name><surname>Sitia</surname><given-names>R.</given-names></name>
</person-group><article-title>Post-translational regulation of interleukin 1&#x003b2; secretion</article-title><source>Cytokine</source><year>1993</year><volume>5</volume><fpage>117</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1016/1043-4666(93)90050-F</pub-id><pub-id pub-id-type="pmid">8334227</pub-id>
</element-citation></ref><ref id="B48-vetsci-11-00643"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chan</surname><given-names>A.H.</given-names></name>
<name><surname>Schroder</surname><given-names>K.</given-names></name>
</person-group><article-title>Inflammasome signaling and regulation of interleukin-1 family cytokines</article-title><source>J. Exp. Med.</source><year>2020</year><volume>217</volume><fpage>e20190314</fpage><pub-id pub-id-type="doi">10.1084/jem.20190314</pub-id><pub-id pub-id-type="pmid">31611248</pub-id>
</element-citation></ref><ref id="B49-vetsci-11-00643"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>D.</given-names></name>
<name><surname>Yu</surname><given-names>T.</given-names></name>
<name><surname>Chen</surname><given-names>G.</given-names></name>
<name><surname>Brown</surname><given-names>S.A.</given-names></name>
<name><surname>Yu</surname><given-names>Z.</given-names></name>
<name><surname>Mattson</surname><given-names>M.P.</given-names></name>
<name><surname>Thompson</surname><given-names>J.S.</given-names></name>
</person-group><article-title>Effects of NF-&#x003ba;B1</article-title><source>Int. J. Radiat. Biol.</source><year>2001</year><volume>77</volume><fpage>763</fpage><lpage>772</lpage><pub-id pub-id-type="doi">10.1080/09553000110050047</pub-id><pub-id pub-id-type="pmid">11454276</pub-id>
</element-citation></ref><ref id="B50-vetsci-11-00643"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>O&#x02019;Neill</surname><given-names>L.A.</given-names></name>
</person-group><article-title>Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily</article-title><source>Curr. Top. Microbiol. Immunol.</source><year>2002</year><volume>270</volume><fpage>47</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">12467243</pub-id>
</element-citation></ref><ref id="B51-vetsci-11-00643"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Verstrepen</surname><given-names>L.</given-names></name>
<name><surname>Bekaert</surname><given-names>T.</given-names></name>
<name><surname>Chau</surname><given-names>T.L.</given-names></name>
<name><surname>Tavernier</surname><given-names>J.</given-names></name>
<name><surname>Chariot</surname><given-names>A.</given-names></name>
<name><surname>Beyaert</surname><given-names>R.</given-names></name>
</person-group><article-title>TLR4, IL-1R and TNF-R signaling to NF-&#x003ba;B: Variations on a common theme</article-title><source>Cell. Mol. Life Sci.</source><year>2008</year><volume>65</volume><fpage>2964</fpage><lpage>2978</lpage><pub-id pub-id-type="doi">10.1007/s00018-008-8064-8</pub-id><pub-id pub-id-type="pmid">18535784</pub-id>
</element-citation></ref><ref id="B52-vetsci-11-00643"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ma</surname><given-names>T.Y.</given-names></name>
<name><surname>Boivin</surname><given-names>M.A.</given-names></name>
<name><surname>Ye</surname><given-names>D.</given-names></name>
<name><surname>Pedram</surname><given-names>A.</given-names></name>
<name><surname>Said</surname><given-names>H.M.</given-names></name>
</person-group><article-title>Mechanism of TNF-&#x003b1; modulation of Caco-2 intestinal epithelial tight junction barrier: Role of myosin light-chain kinase protein expression</article-title><source>Am. J. Physiol. Gastrointest. Liver Physiol.</source><year>2005</year><volume>288</volume><fpage>G422</fpage><lpage>G430</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00412.2004</pub-id><pub-id pub-id-type="pmid">15701621</pub-id>
</element-citation></ref><ref id="B53-vetsci-11-00643"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Al-Sadi</surname><given-names>R.</given-names></name>
<name><surname>Ye</surname><given-names>D.</given-names></name>
<name><surname>Dokladny</surname><given-names>K.</given-names></name>
<name><surname>Ma</surname><given-names>T.Y.</given-names></name>
</person-group><article-title>Mechanism of IL-1&#x003b2;-induced increase in intestinal epithelial tight junction permeability</article-title><source>J. Immunol.</source><year>2008</year><volume>180</volume><fpage>5653</fpage><lpage>5661</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.180.8.5653</pub-id><pub-id pub-id-type="pmid">18390750</pub-id>
</element-citation></ref><ref id="B54-vetsci-11-00643"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brookes</surname><given-names>P.S.</given-names></name>
<name><surname>Yoon</surname><given-names>Y.</given-names></name>
<name><surname>Robotham</surname><given-names>J.L.</given-names></name>
<name><surname>Anders</surname><given-names>M.W.</given-names></name>
<name><surname>Sheu</surname><given-names>S.-S.</given-names></name>
</person-group><article-title>Calcium, ATP, and ROS: A mitochondrial love&#x02013;hate triangle</article-title><source>Am. J. Physiol. Cell Physiol.</source><year>2004</year><volume>287</volume><fpage>C817</fpage><lpage>C833</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00139.2004</pub-id><pub-id pub-id-type="pmid">15355853</pub-id>
</element-citation></ref><ref id="B55-vetsci-11-00643"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>S.</given-names></name>
<name><surname>Kim</surname><given-names>M.-J.</given-names></name>
<name><surname>Park</surname><given-names>D.Y.</given-names></name>
<name><surname>Chung</surname><given-names>H.J.</given-names></name>
<name><surname>Kim</surname><given-names>C.-H.</given-names></name>
<name><surname>Yoon</surname><given-names>J.-H.</given-names></name>
<name><surname>Kim</surname><given-names>H.J.</given-names></name>
</person-group><article-title>Mitochondrial reactive oxygen species modulate innate immune response to influenza A virus in human nasal epithelium</article-title><source>Antiviral Res.</source><year>2015</year><volume>119</volume><fpage>78</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2015.04.011</pub-id><pub-id pub-id-type="pmid">25930096</pub-id>
</element-citation></ref><ref id="B56-vetsci-11-00643"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tal</surname><given-names>M.C.</given-names></name>
<name><surname>Sasai</surname><given-names>M.</given-names></name>
<name><surname>Lee</surname><given-names>H.K.</given-names></name>
<name><surname>Yordy</surname><given-names>B.</given-names></name>
<name><surname>Shadel</surname><given-names>G.S.</given-names></name>
<name><surname>Iwasaki</surname><given-names>A.</given-names></name>
</person-group><article-title>Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2009</year><volume>106</volume><fpage>2770</fpage><lpage>2775</lpage><pub-id pub-id-type="doi">10.1073/pnas.0807694106</pub-id><pub-id pub-id-type="pmid">19196953</pub-id>
</element-citation></ref><ref id="B57-vetsci-11-00643"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Silwal</surname><given-names>P.</given-names></name>
<name><surname>Kim</surname><given-names>J.K.</given-names></name>
<name><surname>Kim</surname><given-names>Y.J.</given-names></name>
<name><surname>Jo</surname><given-names>E.-K.</given-names></name>
</person-group><article-title>Mitochondrial reactive oxygen species: Double-edged weapon in host defense and pathological inflammation during infection</article-title><source>Front. Immunol.</source><year>2020</year><volume>11</volume><elocation-id>1649</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.01649</pub-id><pub-id pub-id-type="pmid">32922385</pub-id>
</element-citation></ref><ref id="B58-vetsci-11-00643"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bhowal</surname><given-names>C.</given-names></name>
<name><surname>Ghosh</surname><given-names>S.</given-names></name>
<name><surname>Ghatak</surname><given-names>D.</given-names></name>
<name><surname>De</surname><given-names>R.</given-names></name>
</person-group><article-title>Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: A comprehensive evidential insight</article-title><source>Mol. Cell. Biochem.</source><year>2023</year><volume>478</volume><fpage>1325</fpage><lpage>1343</lpage><pub-id pub-id-type="doi">10.1007/s11010-022-04593-z</pub-id><pub-id pub-id-type="pmid">36308668</pub-id>
</element-citation></ref><ref id="B59-vetsci-11-00643"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Riley</surname><given-names>J.S.</given-names></name>
<name><surname>Tait</surname><given-names>S.W.</given-names></name>
</person-group><article-title>Mitochondrial DNA in inflammation and immunity</article-title><source>EMBO Rep.</source><year>2020</year><volume>21</volume><fpage>e49799</fpage><pub-id pub-id-type="doi">10.15252/embr.201949799</pub-id><pub-id pub-id-type="pmid">32202065</pub-id>
</element-citation></ref><ref id="B60-vetsci-11-00643"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cossarizza</surname><given-names>A.</given-names></name>
<name><surname>Pinti</surname><given-names>M.</given-names></name>
<name><surname>Nasi</surname><given-names>M.</given-names></name>
<name><surname>Gibellini</surname><given-names>L.</given-names></name>
<name><surname>Manzini</surname><given-names>S.</given-names></name>
<name><surname>Roat</surname><given-names>E.</given-names></name>
<name><surname>De Biasi</surname><given-names>S.</given-names></name>
<name><surname>Bertoncelli</surname><given-names>L.</given-names></name>
<name><surname>Montagna</surname><given-names>J.P.</given-names></name>
<name><surname>Bisi</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>Increased plasma levels of extracellular mitochondrial DNA during HIV infection: A new role for mitochondrial damage-associated molecular patterns during inflammation</article-title><source>Mitochondrion</source><year>2011</year><volume>11</volume><fpage>750</fpage><lpage>755</lpage><pub-id pub-id-type="doi">10.1016/j.mito.2011.06.005</pub-id><pub-id pub-id-type="pmid">21722755</pub-id>
</element-citation></ref><ref id="B61-vetsci-11-00643"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>West</surname><given-names>A.P.</given-names></name>
<name><surname>Shadel</surname><given-names>G.S.</given-names></name>
</person-group><article-title>Mitochondrial DNA in innate immune responses and inflammatory pathology</article-title><source>Nat. Rev. Immunol.</source><year>2017</year><volume>17</volume><fpage>363</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1038/nri.2017.21</pub-id><pub-id pub-id-type="pmid">28393922</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="vetsci-11-00643-f001"><label>Figure 1</label><caption><p>Porcine epidemic diarrhea virus (PEDV) infects IPEC-J2 cells to promote the secretion of mature interleukin (IL)-1&#x003b2;. PEDV (multiplicity of infection (MOI) = 1) was used to infect IPEC-J2 cells for the specified periods of time. Detection of PEDV N protein expression via Western blot following PEDV infection in IPEC-J2 cells (<bold>a</bold>). mRNA expression (<bold>b</bold>) and Western blot (<bold>f</bold>) analyses of IL-1&#x003b2; levels, as well as the results of an enzyme-linked immunosorbent assay (ELISA) to assess IL-1&#x003b2; secretion in the cell supernatants (<bold>c</bold>). IPEC-J2 cells were infected with PEDV at the specified dose for 24 h, followed by fluorescence quantification (<bold>d</bold>), Western blotting (<bold>g</bold>), and the ELISA detection of IL-1&#x003b2; secretion in the cell supernatant (<bold>e</bold>). Data represent the mean &#x000b1; SD (<italic toggle="yes">n</italic> = 3). * <italic toggle="yes">p</italic> &#x0003c; 0.05, ** <italic toggle="yes">p</italic> &#x0003c; 0.01.</p></caption><graphic xlink:href="vetsci-11-00643-g001" position="float"/></fig><fig position="float" id="vetsci-11-00643-f002"><label>Figure 2</label><caption><p>PEDV promotes caspase-1 enzymatic activity in IPEC-J2 cells. Caspase-1 enzyme activity (<bold>a</bold>) and Western blot results (<bold>b</bold>) at the specified time points after the PEDV infection of IPEC-J2 cells (MOI = 1). Caspase-1 enzyme activity (<bold>c</bold>) and Western blot results (<bold>d</bold>) of IPEC-J2 cells infected with PEDV at the specified doses for 24 h. IPEC-J2 cells were treated with the caspase-1 inhibitor, Ac-YVAD-cmk, at the specified concentration for 1 h and then inoculated with PEDV (MOI = 1). ELISA was used to detect IL-1&#x003b2; secretion in the cell supernatant 24 h after infection (<bold>e</bold>). Data represent the mean &#x000b1; SD (<italic toggle="yes">n</italic> = 3). * <italic toggle="yes">p</italic> &#x0003c; 0.05, ** <italic toggle="yes">p</italic> &#x0003c; 0.01.</p></caption><graphic xlink:href="vetsci-11-00643-g002" position="float"/></fig><fig position="float" id="vetsci-11-00643-f003"><label>Figure 3</label><caption><p>PEDV infection of IPEC-J2 cells activates the NLRP3 inflammasome. PEDV was used to infect IPEC-J2 cells at the specified doses for 24 h and then the <italic toggle="yes">NLRP3</italic> inflammasome (<bold>a</bold>) and <italic toggle="yes">ASC</italic> (<bold>c</bold>) mRNA expression were analyzed. <italic toggle="yes">NLRP3</italic> (<bold>b</bold>) and <italic toggle="yes">ASC</italic> (<bold>d</bold>) mRNA expression in IPEC-J2 cells infected with PEDV (MOI = 1) for the specified times. NLRP3 (<bold>e</bold>) and ASC (<bold>f</bold>) rabbit-derived primary antibodies were used as bait antibodies and rabbit serum was used as the negative control antibody in a co-immunoprecipitation experiment. Data represent the mean &#x000b1; SD (<italic toggle="yes">n</italic> = 3). * <italic toggle="yes">p</italic> &#x0003c; 0.05, ** <italic toggle="yes">p</italic> &#x0003c; 0.01.</p></caption><graphic xlink:href="vetsci-11-00643-g003" position="float"/></fig><fig position="float" id="vetsci-11-00643-f004"><label>Figure 4</label><caption><p>PEDV-infected IPEC-J2 cells secrete IL-1&#x003b2; through NLRP3 inflammasome activity. IPEC-J2 cells were treated with 10 &#x000b5;M MCC950 for 1 h, and negative control cells were treated with DMSO for the same time. After 24 h of cell infection with PEDV (MOI = 1), IL-1&#x003b2; secretion in the cell supernatants was detected by ELISA (<bold>a</bold>) and <italic toggle="yes">IL-1&#x003b2;</italic> mRNA quantified by fluorescence (<bold>c</bold>). siNLRP3 and siCtrl (control) were transfected into IPEC-J2 cells. PEDV was used to infect cells (MOI = 1) for 24 h, IL-1&#x003b2; secretion in the cell supernatants was detected by ELISA (<bold>b</bold>), and <italic toggle="yes">IL-1&#x003b2;</italic> mRNA expression was quantified by fluorescence (<bold>d</bold>). Western blot of IPEC-J2 cells treated with 10 &#x000b5;M MCC950 (<bold>e</bold>) and siNLRP3 transfection of IPEC-J2 cells to detect the expression of inflammasome proteins (<bold>f</bold>). Data represent the mean &#x000b1; SD (<italic toggle="yes">n</italic> = 3),** <italic toggle="yes">p</italic> &#x0003c; 0.01.</p></caption><graphic xlink:href="vetsci-11-00643-g004" position="float"/></fig><fig position="float" id="vetsci-11-00643-f005"><label>Figure 5</label><caption><p>PEDV infection causes mitochondrial dysfunction and results in mitochondrial reactive oxygen species (mtROS) production and mitochondrial DNA (mtDNA) release. Mitochondrial membrane potential was decreased (<bold>a</bold>). Reduced ATP production after PEDV infection (<bold>b</bold>). Flow cytometry fluorescence intensity analysis of mtROS production after PEDV infection (<bold>c</bold>). Immunofluorescence showing mtDNA release after PEDV infection (<bold>d</bold>). Data represent mean &#x000b1; SD (<italic toggle="yes">n</italic> = 3), ** <italic toggle="yes">p</italic> &#x0003c; 0.01.</p></caption><graphic xlink:href="vetsci-11-00643-g005" position="float"/></fig><fig position="float" id="vetsci-11-00643-f006"><label>Figure 6</label><caption><p>mtROS are involved in NF-&#x003ba;B activation in PEDV-infected IPEC-J2 cells. IPEC-J2 cells were infected with PEDV at the specified doses for 24 h and the expression levels of pp65 and p65 detected by Western blot (<bold>a</bold>). IPEC-J2 cells were treated with the NF-&#x003ba;B inhibitor BAY11-7082 (10 &#x003bc;M). <italic toggle="yes">IL-1&#x003b2;</italic> mRNA expression was detected 24 h after PEDV infection (MOI = 1) (<bold>b</bold>) and IL-1&#x003b2; secretion in the cell supernatant detected by ELISA (<bold>c</bold>). Western blot to assess the expression of pp65, p65, and IL-1&#x003b2; proteins (<bold>d</bold>). After IPEC-J2 cells were treated with 10 &#x000b5;M Mito-TEMPO for 1 h, <italic toggle="yes">IL-1&#x003b2;</italic> mRNA expression was detected following PEDV infection (MOI = 1) for 24 h (<bold>e</bold>) and IL-1&#x003b2; secretion in the cell supernatant detected by ELISA (<bold>f</bold>). Data represent mean &#x000b1; SD (<italic toggle="yes">n</italic> = 3), ** <italic toggle="yes">p</italic> &#x0003c; 0.01.</p></caption><graphic xlink:href="vetsci-11-00643-g006" position="float"/></fig><fig position="float" id="vetsci-11-00643-f007"><label>Figure 7</label><caption><p>mtDNA participates in NLRP3 inflammasome activation in PEDV-infected IPEC-J2 cells. After transfection with DNase I, IPEC-J2 cells were infected with PEDV (MOI = 1). IL-1&#x003b2; mRNA expression (<bold>a</bold>) and secretion in cell supernatants detected by ELISA (<bold>b</bold>). <italic toggle="yes">NLRP3</italic> inflammasome mRNA expression (<bold>c</bold>) and caspase-1 enzyme activity (<bold>d</bold>). Western blot detection of NLRP3 inflammasome and downstream protein expression after transfection with DNase I protein (<bold>e</bold>). Data represent mean &#x000b1; SD (<italic toggle="yes">n</italic> = 3). ** <italic toggle="yes">p</italic> &#x0003c; 0.01.</p></caption><graphic xlink:href="vetsci-11-00643-g007" position="float"/></fig><fig position="float" id="vetsci-11-00643-f008"><label>Figure 8</label><caption><p>Schematic showing that PEDV infection leads to cytoplasmic mitochondrial DNA release and the activation of the NLPR3 inflammasome.</p></caption><graphic xlink:href="vetsci-11-00643-g008" position="float"/></fig><table-wrap position="float" id="vetsci-11-00643-t001"><object-id pub-id-type="pii">vetsci-11-00643-t001_Table 1</object-id><label>Table 1</label><caption><p>qPCR primer sequences.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gene</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Forward Primer (5&#x02032;&#x02013;3&#x02032;)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reverse Primer (5&#x02032;&#x02013;3&#x02032;)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">IL-1&#x003b2;</td><td align="center" valign="middle" rowspan="1" colspan="1">AAGAGGGACATGGAGAAGCGATTTG</td><td align="center" valign="middle" rowspan="1" colspan="1">TTGTTCTGCTTGAGAGGTGCTGATG</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">NLRP3</td><td align="center" valign="middle" rowspan="1" colspan="1">TGTATTGAGAACTGTCGCCATGTGG</td><td align="center" valign="middle" rowspan="1" colspan="1">CTCCTCTTCCTCCTCCTCCTCTTTG</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">GAPDH</td><td align="center" valign="middle" rowspan="1" colspan="1">GATTCCACCCACGGCAAGTTCC</td><td align="center" valign="middle" rowspan="1" colspan="1">AGCACCAGCATCACCCCATTTG</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ASC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GAAGGTGCTGACGGAAGAGC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TCCTTGCAGGTCAGGTTCCA</td></tr></tbody></table></table-wrap><table-wrap position="float" id="vetsci-11-00643-t002"><object-id pub-id-type="pii">vetsci-11-00643-t002_Table 2</object-id><label>Table 2</label><caption><p>Synthetic siRNA sequences.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">siRNA </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sense (5&#x02032;&#x02013;3&#x02032;)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Anti-Sense (5&#x02032;&#x02013;3&#x02032;)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">siNLRP3</td><td align="center" valign="middle" rowspan="1" colspan="1">CGGUUAAGUUGUCUCAAAUTT</td><td align="center" valign="middle" rowspan="1" colspan="1">AUUUCACAGTTCUUAAGGCTT</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">siCtrl</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">UUCUCCGAACGUGUCACGUTT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ACGUGACACGUUCGGAGAATT</td></tr></tbody></table></table-wrap></floats-group></article>